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C. albicans is an important fungal pathogen of humans, and an understanding of 
the regulation of its cell cycle may reveal new targets for anti-fungal therapies. We 
previously characterized the C. albicans Anaphase Promoting Complex/Cyclosome 
regulatory co-factors Cdc20p and Cdh1p, and showed that they are important for the 
metaphase-to-anaphase transition and mitotic exit. In order to determine the mechanisms 
of action of Cdc20p, we searched the genome for factors that bind it in other systems, and 
found that C. albicans lacks the conserved Cdc20p target, securin. Securins bind and 
prevent separase from cleaving cohesin, and must be targeted for degradation by Cdc20p 
for separase-dependent sister chromatid separation. We hypothesized that C. albicans 
contains a divergent securin, which may be uncovered by identifying proteins that bind 
separase. We demonstrated that the C. albicans separase homologue, ESP1, is required 
for chromosome segregation. We then identified Esp1p-interacting factors using affinity 
purification and mass spectrometry, and uncovered Orf19.955p, a protein of unknown 
function with homologues only in Candida species. Orf19.955p contains Destruction and 
a KEN box, like other securins. While not essential, depletion impairs cell growth and 
phenotype. Chromosomes could segregate; unlike in Esp1p-depleted cells, but 
chromosome organization and microtubules were adversely affected. In contrast, 
depletion of securin Pds1p in S. cerevisiae prevented chromosome separation and 
phenocopied absence of Esp1p. Future experiments will clarify if Orf19.955p is a 
securin. Collectively our results provide new insights on factors involved in the 
metaphase-to-anaphase transition, and thus cell proliferation in C. albicans, including a 
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1.1 Cell Cycle Regulation   
1.1.1 Overview 
  The cell cycle is the process that governs duplication of DNA and subsequent division of 
the cell. In most eukaryotes it is composed of several phases, including G1, S, G2 and M phase, 
followed by cytokinesis. During G1 phase, many cell types will grow. S phase is characterized by 
duplication of genetic material and expression of histones required for DNA assembly. During 
G2 phase, growth can again occur in some cell types (1). Mitosis involves the alignment of 
duplicated chromosomes on a spindle, and their separation to opposite poles. Mitosis is then 
followed by cytokinesis, which results in the formation of daughter cells (1).  
 
1.2 Mitosis 
1.2.1 Overview of stages  
  Mitosis consists of various stages including prophase, metaphase, anaphase and telophase.  
In mammalian cells, during prophase, chromatin condenses into chromosomes and centrosomes 
nucleate microtubules. The nuclear envelope and nucleolus break down and the chromosomes are 
captured by the spindle microtubules. During metaphase, the chromosomes align at the cell 
equator. During anaphase, the chromosomes separate through degradation of the cohesin “glue” 
that held them together, and move to opposite poles of the cell. Finally, telophase is characterized 
by sister chromosomes reaching opposite poles of the spindle, and reformation of the nuclear 
envelope. Telophase is followed by cytokinesis, where the daughter cells separate. In the model 
yeast Saccharomyces cerevisiae, differences are seen with respect to the nuclear envelope, which 
does not break down but does form pores (2), as well as spindle assembly, which occurs earlier in 
S phase (3). 
 
1.2.2 Regulation of the G2/M transition: Mitosis Promoting Factor (MPF) 
A major regulator of many cell cycle transitions involves a Cyclin Dependent Kinase 
(CDK) interacting with a phase-specific cyclin. During the G2/M transition, a CDK interacts with 
a mitotic Cyclin B to form Mitosis Promoting Factor (MPF). In the model yeast Saccharomyces 
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cerevisiae, MPF consists of the CDK Cdc28p and the cyclin B Clb2p (4). The Cdc28p/Clb2p 
complex is held inactive at the G2/M transition by inhibitory phosphorylation from Swe1p 
kinase. The phosphatase Mih1p can activate Cdc28p/Clb2p by removing the inhibitory 
phosphate. In mammals, Cyclin B associates with Cdk1, which is also inactive due to 
phosphorylation by Wee1 and Myt1. Cdc25p dephosphorylates and activates CDK/Cyclin B to 
initiate the G2/M transition (5). Targets of MPF include proteins associated with the nuclear 
lamina and Golgi apparatus, for example, triggering their breakdown, factors required for spindle 
assembly, chromosome condensation, and activation of other processes required for mitotic 
progression.  MPF activity must be down regulated in order for cells to exit mitosis, which occurs 
in part through targeted degradation of the B-type cyclin (6,7). 
 
1.2.3 Regulation of the metaphase-to-anaphase transition   
(a) Separase 
  The metaphase-to-anaphase transition is characterized by the separation of duplicated 
chromosomes to opposite poles of the spindle, and this requires the activity of separase, a 
cysteine-rich protease that helps cleave the glue holding chromosomes together. The « glue » 
consists of a cohesin complex, and this must be removed in order for the chromosomes to 
separate (8). The cohesin complex is composed of two core SMC proteins Smc1p and Smc3p, as 
well as two non-SMC kleisin proteins, Scc1p and Scc3p, which are highly conserved (8) (Fig. 
1A). The alpha-kleisin subunit of the cohesin complex (Scc1p) is one of the main substrates of 
separase. Separases are highly conserved proteins, where conservation is found in the ARM 
repeat sequences at the N-terminus. Some common separases include Esp1p from S. cerevisiae 
(9), Cut1p from Shizosaccharomyces pombe (10), bimB from A. nidulans (11), ESP1 from 
humans and mouse (12), and Sep-1 from C. elegans (13), for example. They are composed of 
three main domains, the tail, trunk, and head. The head domain in the C-terminus is the most 
conserved and contains catalytic caspase-like domains, whereas the tail in the N-terminus 
consists of Armadillo (ARM) repeats that form a super helix of alpha helices that mediate 
protein-protein interactions (14, 15). In S. cerevisiae, ESP1 is essential and its absence results in 
large-budded cells with unsegregated chromatin predominantly located in the daughter bud. 
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Spindles were abnormal in most cells, resembling discontinuous microtubule arrays that were 
often curved around the perimeter of the cell, or were very weak in staining, while a smaller 
proportion of cells contained a short G2 spindle (16). Long-term absence resulted in 
accumulation of extra spindle poles (17). Buds that did not receive DNA went on to form 
hypoploid cells that remained unbudded, whereas the daughter cells that acquired the DNA could 
undergo budding and at least one more round of DNA synthesis (16). In S. cerevisiae, when cells 
are depleted of Cdc20p and Esp1p is overexpressed simultaneously, levels of the Esp1p repressor 
Pds1p increase and fully elongated spindles form (18). The ability of separase to cleave Scc1p in 
mammals and S. cerevisiae, for example, is enhanced by previous phosphorylation of Scc1p by 
polo-like kinases such as Plk1p or Cdc5p (19, 20, 21, 22). Esp1p and Cut1p localize to the 
spindle pole bodies and spindles prior to and during anaphase, while human separase is 
associated with the centrosome (14).   
 Separases are linked to other functions. For example, in S. cerevisiae, Esp1p also cleaves 
Slk19p, a kinetochore and spindle-associated protein, which then functions in stabilizing the 
spindle during anaphase (23). Esp1p is also thought to play a role in the Cdc14 early anaphase 
release pathway (FEAR; see below) but in a non-proteolytic manner (24, 25), through down-
regulating the phosphatase PP2A
cdc55
, allowing phosphorylation of Net1p and initial release of 



























Fig 1: Cohesin complex and its role in sister chromatid separation. 
(A) Cohesin complex subunits (6) (B) Key protein factors involved in sister chromatid separation 
during metaphase-to-anaphase transition. 
 
(b) Securin 
 Esp1p is regulated in part by securin. Securin homologues are not well conserved at the 
sequence level, but some homology exists between Pds1p and Cut2p in S. cerevisiae or S. pombe, 
respectively (9, 10), as well as PTTG1p in humans (12) and Pimp in Drosophila (26). Securins 
have not been identified to date in other fungi and in plants (14). Of the known homologues, the 
proteins share regions of charged amino acids (27). Securins bind separase at specific binding 
sites, which slightly differ between organisms. For example, in fission yeast, the N-terminus of 
separase binds the C-terminus of securin, whereas in budding yeast, the C-terminus of Pds1p 
interacts with the first 156 amino acids of the N-terminus in separase as well as other amino acid 
sites (14).   
 In S. cerevisiae, Pds1p acts as both an inhibitor and activator of Esp1p (27). As a 
repressor, Pds1p, for example, binds Esp1p and inhibits it from cleaving the Scc1 subunit of the 





through preventing the N and C termini of Esp1p from interacting. As an activator it may assist in 
Esp1p folding (27) and promotes efficient nuclear localization of Esp1p from the cytoplasm (28).  
 In S. cerevisiae, Pds1p is not essential but important for growth at elevated temperatures. 
In S. cerevisiae, PDS1 mutants displayed precocious separation of chromosomes in the presence 
of microtubule inhibitors. In the absence of the drugs, 75% of PDS1 temperature-sensitive 
mutants grown at restrictive temperature were large-budded cells with a single chromosomal 
mass of DNA, while the remaining cells were unbudded aneuploid cells (9). This phenotype is 
due to the fact that Pds1p is both an activator and repressor of Esp1p. Pds1p mutants can form 
spindles, but were not fully elongated as most large-budded cells contained bar spindles 
characteristic of metaphase or were shorter in length (9). Cytokinesis was not impaired, as septa 
were observed bisecting DNA and aploid cells could form, and cells could enter the next cell 
cycle based on duplication of DNA and spindle pole bodies. At permissive temperature, some 
chromosome segregation defects were evident, resulting in only 40% of cells being able to form 
colonies, which were often very small and/or heterogeneous in size (9). Expression of a non-
degradable version of Pds1p arrests cells in metaphase (18). In the absence of Pds1p, another 
protein, the phosphatase PP2A, becomes essential. PP2A prevents cohesin cleavage by 
antagonizing the promoting activity of Cdc5p phosphorylation of Scc1p (29). Human PTTG1p is 
also not essential (30) and has other mechanisms to compensate for loss of chromosome 
segregation genes (31). For example, a study has shown that Cdk1p binds phosphorylated 
separase in conjunction with its regulatory subunit Cyclin B1 (32). This in turn inhibits separase 
as well as the kinase (32). In other organisms, such as S. pombe and D. melanogaster securins are 
essential (33).  
 Securin is regulated in several ways. In S. cerevisiae, Pds1p is cyclic, where it is induced 
after G1 phase but degraded at anaphase onset (9). Securin can also be phosphorylated as a result 
of DNA or spindle damage, or by the mitotic Cdk regulator, Cdc28p (34). During DNA damage 
in S. cerevisiae, the kinase Chk1p acts on Pds1p to ensure anaphase does not proceed (35, 36). 
During a normal cell cycle, Cdc28p phosphorylates Pds1p during mitosis, which allows it to 
interact with Esp1p more efficiently as well as enhance its ability to influence the nuclear 




(c) Anaphase Promoting Complex/Cyclosome (APC/C)  
 Securin is bound to Esp1p during early stages of mitosis. In order for securin to be 
removed and thus liberate separase, the Anaphase Promoting Complex/Cyclosome (APC/C), 
another conserved regulatory network governing mitotic progression, must target it for 
degradation (Fig. 2). The APC/C is an ubiquitin ligase system that targets proteins for destruction 
through assembling a chain of ubiquitin tags on substrates. Such tags are recognized by the 26s 
proteasome and destroyed at the appropriate time. The APC/C is composed of 11 to 13 subunits 
and contains a core cullin subunit (Apc2p) as well as a RING subunit (Apc11p), which is 
responsible for binding the E2-ubiquitin conjugate (37). 
 APC/C activity is under control of two major co-factors, one of which is Cdc20p. One of 
the major targets of APC
Cdc20
 is securin, as well as B-type cyclins such as Clb2p and Clb5p in S. 
cerevisiae, for example  (38, 39, 40, 41). In S. cerevisiae, CDC20 mutants arrest in metaphase, 
but absence of PDS1 in this background results in a telophase arrest, suggesting that Cdc20p is 
important for both the metaphase to anaphase transition as well as mitotic exit (42). Cdc20p is 
regulated at multiple levels. CDC20 transcription is activated by Cks1p, a protein that interacts 
with CDK (43). Cdc20p protein levels are cell cycle regulated, where destruction in late 
mitosis/G1 is initiated by activation of the APC via another co-factor, Cdh1p (38, 42, 43, 44, 45).  
Cdc20p is also a target of the spindle checkpoint; upon spindle damage, checkpoint factors such 
as Mad2p form an inhibitory complex with Cdc20p, thus preventing APC/C activation and 





















Fig 2: The Anaphase Promoting Complex/Cyclosome (APC/C), its targets and effect on 
mitotic progression. 
 
 A second APC/C co-activator is Cdh1p (Fig. 2). The APC/C falls under control of Cdh1p 
later in mitosis, and targets Cdc20p, the remainder of mitotic cyclins, other mitotic regulators 
such as the polo like kinase Cdc5p, and various proteins required for spindle function during 
degradation (49). CDH1 is not essential in S. cerevisiae. Cells lacking the protein are very small, 
and grow slightly slower than the wild-type cells, and show a delay in telophase, indicating a role 
in mitotic exit (44, 50). Cdh1p levels are constant throughout the cell cycle, and its activity is 
negatively regulated by phosphorylation via CDK activity (45, 51, 52, 53). In order to be 
activated, it requires dephosphorylation by the phosphatase Cdc14p. Cdh1p activity is also 
negatively regulated by the spindle checkpoint pathway, since it is important for mitotic exit.   
 
(c) Mitotic Exit Network (MEN) and Cdc14 Early Anaphase Release (FEAR) pathways  
 In S. cerevisiae, additional major regulatory circuits that control the metaphase to 
anaphase transition and eventual mitotic exit are the FEAR and MEN pathways (7). These 
pathways function to control release of the phosphatase Cdc14p from its inhibitor, Net1p, in the 
nucleolus, thereby allowing dephosphorylation of mitotic CDK targets, inactivation of CDK, and 
mitotic exit (7). The FEAR pathway functions during early anaphase to allow initial and transient 
release of Cdc14p. It consists of the separase Esp1p, Slk19p, and Spo12p, which inactivate the 
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phosphatase PP2A, resulting in enhanced phosphorylation of Net1p and initial release of Cdc14p.  
Cdc5p contributes to this process by interacting with Cdc14p and Esp1p (54, 55). Accumulation 
of Cdc14p results in the activation of the MEN at the spindle pole body by allowing for one 
spindle pole body to enter the bud at anaphase (56). The MEN pathway activation maintains 
Cdc14p release, allowing eventual mitotic exit. Here, Cdc5p negatively regulates the GTPase-
activating protein (GAP) complex Bub2p-Bfa1p. This in turn negatively regulates the Ras-like 
Tem1p GTPase. Tem1p is localized to the daughter spindle pole bodies where it is activated by 
Lte1p, a guanine exchange factor (GEF) for Tem1p, only in the bud (Fig 3B) (57). The active 
form of Tem1p leads to a protein kinase signaling cascade including Cdc15p, Dbf2p and Mob1p, 
which function in releasing the remaining Cdc14p phosphatase from the nucleolus through 
phosphorylation (58). Released Cdc14p dephosphorylates Sic1p, a Cdk inhibitor, and Swi5p, a 
transcription factor for SIC1, resulting in down-regulation of Cdc28p/Clb2p activity. This is 
further enhanced by Cdc14p-mediated dephosphorylation of the APC/C cofactor Cdh1p, which in 









































Fig 3: Mitotic regulatory pathways. 
(A) Cdc14p early anaphase release pathway (FEAR) (6). (B) Mitotic exit network (MEN) (57). 
 
1.3 Candida albicans  
1.3.1 General overview 
Candida albicans is an ascomycete fungus that is normally a commensal in human 
gastrointestinal and urogenitary tracks (59). However, under conditions of immune suppression, 
such as in individuals suffering from HIV or undergoing chemotherapy treatments, it can be 
pathogenic, causing mucosal infections such as thrush or vaginitis, or more serious systemic 





associated with up to 50% mortality rates (60). In order to treat infection, several classes of 
antifungal drugs are currently in use. Azoles such as fluconazole affect cell membrane 
development through targeting ergesterol synthesis (61) and are fungistatic. On the other hand, 
the polyene Amphotericin B inserts within lipid bilayers and binds to sterols, resulting in the 
formation of small pores that disrupt membrane integrity and is thus fungicidal (61). Other drugs 
including the fluoropyrimidines and the echinocandins target nucleic acid synthesis and cell wall 
development, respectively, and are also fungistatic towards selective Aspergillus species (62).  
However, some antifungal drug targets have homologues in humans, resulting in toxic side 
effects (61), and C. albicans is showing increased resistance to some drug treatments (63). Thus, 
there is a need to identify additional drug targets and develop new anti-fungal therapies, which in 
turn requires a comprehensive understanding of the basic biology of C. albicans.  
 
1.4 Virulence-determining trait: Morphogenesis 
1.4.1 Cell types  
Virulence in C. albicans is dependent on a number of processes and factors. For example, 
adherence to host cells is important and mediated by biomolecules termed adhesins, including 
those that belong to the ALS family. These aid C. albicans cells in colonizing endothelial and 
epithelial cells (64, 65). For host cell invasion, C.albicans cells utilize induced endocytosis and 
active penetration (65). Through the endocytosis pathway, specialized proteins called invasins 
line the cell surface, bind host cells and trigger them to engulf the virulent cells (65). Active 
penetration requires viable C albicans hyphae as well as certain proteases including the SAPs and 
phospholipases (65).   
 Another process that is important for virulence is the ability of C. albicans to undergo 
morphological changes between yeast, pseudohyphal and hyphal forms under specific 
environmental conditions (Fig. 4). Yeast cells grow via budding that initiates at the G1/S 
transition of the cell cycle, and a ring of septins marks the future bud emergence site. Initial bud 
outgrowth is polar, and associated with a high concentration of actin patches and a polarisome, 
but switches to an isometric mode near mitosis, when the actin patches disperse evenly around 
the bud and polarisome components re-locate to the bud neck (66, 67, 68). Nuclear division takes 
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place across the mother-bud neck, followed by septation and cytokinesis (69). Yeast cells fall into 
two classes, white or opaque (70). White phase yeast cells are more round, grow into cream-
colored colonies and are incapable of mating. The less frequent opaque cells are enlarged, bean-
shaped yeast that are mating form of C. albicans by virtue of being homozygous at the mating 
type locus (71). White phase yeast cells can switch to filamentous cell forms, including 
pseudohyphae and hyphae. Pseudohyphae are chains of elongated yeast cells with an extended 
G2 phase that do not separate after cytokinesis, and show constrictions at septation sites (72).  
Hyphae are distinct in that they initiate and maintain polarized growth, and thus maintain a high 
concentration of actin patches at the tip. The first nuclear division takes place within the germ 
tube and not at the bud neck (72). Hyphae contain a polarisome but also a proposed vesicle 
supply center, called the Spitzenkörper, in the tips (68, 74). Spitzenkörper components such as 
the myosin light chain Mlc1p are maintained at the growing tip and simultaneously localize to 
subapical septation sites. Hyphae lack constrictions at septation sites, and do not have extended 
cell cycle phases like pseudohyphae, indicating that hyphal growth runs independently of the cell 
cycle (67, 72). This plasticity in form is crucial for survival in the host and virulence, because 
cells locked in one mutant form lose their pathogenicity (71). The yeast cells are thought to be 
optimal for dissemination in the bloodstream, whereas the filamentous forms are more adept at 











Fig 4: Cell types in Candida albicans produced from mitotic arrest.  
(A) Yeast. (B) Pseudohyphal cell. (C) Elongated filaments produced from mitotic arrest with 
nucleus in daughter cell. (D) Hyphal cell. 
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1.4.2 Environmental Regulation of Morphogenesis 
 
The regulation of morphogenesis involves environmental cues and associated signaling 
pathways. For example, yeast, pseudohyphae and hyphae grow at 30, 36 or 37C, respectively.  
Hyphae additionally require factors such as serum, a pH between 6 and 7, or alternative carbon 
sources to form (72). The yeast-to-hyphal transition has been extensively investigated, where 
environmental cues are mediated by a diversity of signaling pathways, including the mitogen-
activated protein kinase (MAPK) and cyclic AMP (cAMP) and others (75), for example. An 
important downstream transcription factor that many of the pathways converge on is Efg1p. 
Efg1p is a master regulator of hyphal growth and expression of hyphal-specific genes (HSGs), 
since cells lacking Efg1p can’t form hyphae under most hyphal-inducing conditions (76) and 
Efg1p is required for expression of many HSGs, including adhesions, proteases and other factors 
required for virulence of hyphae (76). Another HSG that is a target of Efg1p is the transcription 
factor UME6 (75,77). Yeast cells lacking Ume6p initiate but do not maintain hyphal growth, and 
UME6 overexpression can drive hyphal formation under yeast growth conditions (78). Ume6p 
regulates expression of many genes, including HGC1. HGC1 is expressed only in hyphae and is 
homologous to a G1 cyclin, yet is not required for the cell cycle (79). Hgc1p interacts with the 
cyclin-dependent kinase Cdc28p and phosphorylates the Cdc42p inhibitory GTPase activating 
protein (GAP) Rga2p, preventing it from localizing to hyphal tips and thus permitting hyphal 
growth (79). Cdc28p/Hgc1p also phosphorylates Efg1p, which targets it to promoters of genes 
that repress cell separation in hyphae (80) and Sec2p, a secretory vesicle-associated protein that is 
specifically localized to the Spitzenkörper (81). The yeast-to-hyphal transition can also be 
negatively regulated by other transcription factors, including Tup1p, Nrg1p and Rfg1p (76).  
 
1.4.3 Virulence-determining trait: Cell proliferation  
1.4.3.1 General   
 Cell proliferation is another biological process that is crucial for survival in the host and 
for virulence. However, cell cycle regulation has not been well characterized in Candida 
albicans. At a transcriptional level, there are similarities in cell cycle phase-specific modulated 
genes compared to other yeast systems including S.cerevisiae and S. pombe (82). However there 
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were also many differences, including modulation of Candida-specific and/or uncharacterized 
genes. Several putative cell cycle-associated and regulatory proteins remain to be characterized in 
C. albicans, of those that have been analyzed, many show variation in function compared to 
homologues in other systems, including yeast and mammals. This suggests the existence of novel 
features in the cell cycle circuitry in C. albicans, which may be exploited for the purpose of new 
drug target discovery.  
 
1.4.3.2 Regulation of mitosis in C. albicans  
(a) MPF, FEAR and MEN homologues 
 In C. albicans, little is known about the regulation of mitosis. Of the factors that have 
been characterized, several show variations or differences in function in C. albicans compared to 
orthologues in S. cerevisiae, suggesting re-wiring in the mitotic networks, or mechanisms of 
action remain unclear. For example, homologues of the CDK Cdc28p and the B-type cyclin 
Clb2p exist. Absence of either results in a mitotic arrest but Clb2p-depleted cells were arrested in 
telophase (83), while the arrest point for Cdc28p-depleted cells was not determined (84). Further, 
regulation of Cdc28p/Clb2p and targets remain elusive. With respect to MEN and FEAR 
pathways, C. albicans contains a homologue of CDC14 but unlike the situation in S. cerevisiae, it 
is not essential and is required in late telophase (85, 52). DBF2 in C. albicans is essential and 
required spindle formation, cytokinesis, septum formation, and exit from mitosis in C. albicans 
(86), while S. cerevisiae DBF2 is not essential and is required for mitotic exit and cytokinesis 
(87). The GTPase Tem1p, however, is essential for mitotic exit, cytokinesis and cell separation in 
both S. cerevisiae and C. albicans, C. albicans also contains a homologue of the polo-like kinase, 
Cdc5p, but it is required earlier in the cell cycle in C. albicans compared to S. cerevisiae (88).  
 Intriguingly, many of the factors that are essential for mitosis in C. albicans result in a 
novel phenotype upon depletion, where the yeast cells grow into long filaments as opposed to 
arresting as large doublets (Fig. 4) (88). We recently demonstrated that the filaments associated 
with Cdc5p depletion were elongated buds that failed to switch from polar to isometric growth, 
and then adapted a hyphal fate over time. This required delayed activation of a core hyphal 
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regulator, the transcription factor Ume6p (89), but the mechanism linking mitotic arrest to 
changes in polar growth at the bud tip and subsequent activation of Ume6p remain unclear.  
(b) APC/C cofactors Cdc20p and Cdh1p 
 With respect to the APC/C, orthologues of Cdc20p and Cdh1p were partially 
characterized in a previous report by conducting a series of biochemical and genetic analyses 
(90). In order to determine the function of Cdc20p, a strain was constructed where one copy of 
the gene was placed under control of a conditional promotor. DAPI staining and tubulin 
localization demonstrated that cells depleted of Cdc20p were arrested in metaphase or telophase. 
Further, the mitotic cyclin Clb2p as well as the polo-like kinase Cdc5p were enriched, suggesting 
that Cdc20p shows conservation in function as well as targets in regulating mitosis in C. albicans.  
In order to determine the function of Cdh1p, a deletion strain was created and the gene was not 
essential. DAPI staining and tubulin localization showed that a high proportion of cdh1/cdh1 
cells contained a telophase spindle, and enriched Clb2p and Cdc5p, suggesting a delay in 
telophase, similar to the situation in S. cerevisiae. Thus, C. albicans Cdh1p has some conserved 
function in regulating mitotic exit in Candida albicans.  
However, other results suggest additional novel features or functions associated with C. 
albicans Cdc20p and Cdh1p. For example, cells depleted of Cdc20p formed elongated filaments, 
and did not arrest as large doublets as seen in S. cerevisiae cdh1 cells (90). Further, C.albicans 
lacks a sequence orthologue of the conserved Cdc20p target, securin. In addition, cells depleted 
of Cdh1p showed a pleiotropic phenotype, and of the yeast form cells, the size was significantly 
larger than control yeast cells. In contrast, S. cerevisiae cdh1 cells are one of the smallest cell 
size mutants in this system (90). Thus, Cdc20p and Cdh1p in C. albicans are important for 
mitosis and morphogenesis, and may have some novel functions and mechanisms of action.  
These results further underscore differences in the mitotic machinery in C. albicans relative to 
other systems, including mammals.  
Thus, some key factors controlling mitosis have been identified in C. albicans, but a 
comprehensive picture of the mitotic regulatory networks and how arresting mitosis may lead to 
changes in bud growth pattern is lacking. Specifically, the mechanisms of action of Cdc20p and 
Cdh1p remain unclear, particularly in the context of governing the metaphase-to-anaphase 
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transition, due to the absence of a securin homologue and lack of characterization of other 
putative regulators, including separase, in this organism.   
 
1.5 Objectives 
The primary aim of this thesis is to determine the mechanisms of action of Cdc20p, and 
thereby gain insight on the regulation of mitosis and the metaphase-to-anaphase transition in C. 
albicans. We hypothesize that Cdc20p may function in part through targeting a divergent yet 
functional homologue of a securin, and that this may be identified through determining the 
interacting proteins of the conserved separase Esp1p. C. albicans contains a homologue of Esp1p, 
but to date it has not been fully characterized. Our specific objectives include: 1) Characterize the 
Esp1p homologue in C. albicans and determine whether it plays a conserved role in chromosome 
separation; 2) Identify the interacting factors of Esp1p in order to gain insight on its mechanisms 
of action and identify a putative Securin homologue; and 3) Validate the physical interaction 
between Esp1p and novel proteins, and further characterize these proteins to determine whether 

















2.0. Materials and Methods 
2.1 Strains, oligonucleotides, and plasmids 
      Strains, oligonucleotides and plasmids used in this study are listed in Tables 1, 2 and 3, 
respectively.   
Table 1: Candida albicans strains used in this study 
Strain Genotype Source 
 
BWP17 ura3:imm434/ura3:imm434, his1::hisG/his1::hisG 
arg4::hisG/arg4::hisG 
 
Wilson et al., 
1999 
 





CLB2-HA-HIS1   Glory, 2014 
AG636 ESP1/ESP1-TAP-URA3  Glory, 2014 
 
HCCA1 cdc20::URA3/CDC20 Chou et al., 
2011 
HCCA109 cdc20::URA3/MET3::CDC20-HIS1 Chou et al., 
2011 
HCCA118 MET3::CDC5-HIS1/cdc5::URA3                                                                                   Chou et al.,
2011 
SS1, 5 esp1::HIS1/ESP1-TAP-URA3 This study 









   
SS20, 21 esp1::URA3/ESP1                                                         This study 
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SS22  orf19.955::URA3/ORF19.955-MYC-HIS1  This study 
SS23-28 orf19.955::URA3/MET3::ORF19.955-HIS1                    This study 
SS29, 30 ORF19.955/ORF19.955-MYC-HIS1,  
ESP1/ESP1-HA-URA3 
This study 
SS31-36 esp1::URA3/MET3::ESP1-HIS1 This study 
SS37 TUB2-GFP-ARG4/TUB2, 





















Table 2: Oligonucleotides used in this study 
 
Oligonucleotide Sequence in 5’- 3’ Direction Source 
















SS3F ATC TGT ATT TCA TTA CAG TTT GAT TCA 
GCC/TAT AGG GCG AAT TGG AGC TC 
This Study 
 
SS3R CAA CAA TTC CAT CAG AAA ATG CCA ACA 
TTA/GAC GGT ATC GAT AAG CTT GA 
This Study 
SS10F GGA ACC ATT AAG AGA GCA TA This Study 
 
SS10R TTG CTA GTT TGG GTG CTA AT This Study 
 
SS18F AAT ACC AAT TAT TGA AGG TAT TGA TGA 
GGA AAT TGG TTT AAC TAG CGA TGA TTT 
GGA TAA TTT ATT AGG AGG TGG TGG TCG 
GAT CCC CGG GTT AAT TAA 
This Study 
 
SS18R AGT ATG AAC AAC AGG GGT ACG AGC AAT 
CAT GTG CCC AAC AAT AAT ACC ATG TAA 
ATA CTC AAT ATA TGA AGA ATT CCG GAA 
TAT TTA TGA GAA AC 
This Study 
SS19F 
















SS21F TTA CTC CCT TCA TTA GCT TAC AAT TGA GTT This Study 
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GGA TCC TGG AGG ATG AGG AG 
 
SS21R CAA TAG TTT TTG ATC CAA CGA GTT ATC 
CAT CAT GTT TTC TGG GGA GGG TA 
This Study 
SS25F 
GGG GGC TTC ATT ATC TAT TT This Study 
SS25R 
GAG AAT CCG ATC AAT TTC CA This Study 
SS26F 
CGA TGG AGA CAT AAG TTT CT This Study 
SS27F 




SS27R TTC CTC ATT TCT CCT TTT AGT GGT TCA ACC This Study 
 








SS29F GGT TGA ACC ACT AAA AGG AGA AAT GAG 
GAA GGA TCC TGG AGG ATG AGG AG 
This Study 
 
SS29R TTG AAT ATC TTT GAA TAT ATG ACT TGA 
CAT CAT GTT TTC TGG GGA GGG TA 
This Study 
 
AG3R GCG GTT GGC TGC TGA GAC GG Glory, 2014 
 
AG 67F TGC TGG TGA TGA GAC CTT ACG ATT TTG 
GAA TGT ATT TGA AAA AAA TAG GCA TAA 
CGA ATC ACC TG CTT CGG TTT TGT TAG GAG 
CAT TTC TGC AGT TGC GCG GTC GAC GGA 
TCC CCG GGTT 
Glory, 2014 
 
AG 67R ACT TGA ATA CAT GCA GAT ACT AGT TAC 
AGA TGA TTT GGG AAA TGT GAC ACT TTC 
ACT TGA ACG ACT TGA AAA TTG GTG CTC 
ACA AAA CAA GGT TGT TCC CTC GAT GAA 
TTC GAG CTC GTT 
Glory, 2014 
AG 68F CTA TAA TAC CCC TAC AGT CT 
 
Glory, 2014 




AG 103F GGA TTT GAC TAA TTG TGT TGT TCA AAG 
TCG AAG TAA ATG TAC TTT GAA ATA CTT 
GAA TGG ATC AGC ACC TGT GGT TTA TGG 
TCT ACC AAT GTA TTT AAA AGG TCG ACG 
GAT CCC CGG GTT 
Glory, 2014 
 
AG 103R AGT GAT TGG GTG CAA AAT TTG TTC ATA 
ACA AAC CAA ACA ATA CAA AAT CAA GAT 
CCA AAT TAT GCT CTT TTT CTT ATT ATT AAA 
ATA TAT AAA CTT ATA TTC GAT GAA TTC 
GAG CTC GTT 
Glory, 2014 
 
CB 135F CAA TAC CAA GAA GCT AGT ATT GAT GAA 
GAA GAA TTA GAA TAT GCC GAT GAA ATC 
CCA TTA GAA GAT GCC GCC ATG GAA GGT 
GCT GGC GCA GGT GCT TC 
Bachewich et al. 
2003 
 
CB 135R ATA TTG TGC CGA TAA ATA ATA AAA GGG 
TAT AAT CAT TAA CTA AAC CAA AAA AAA 
CCA TAA TTA TAT TAG AAG TGA ACA AAG 
ATA TCA TCG ATG AAT TCG A 
Bachewich et al. 
2003 
caURA3F GGT AAT ACC GTG AAG AAA CA Glory, 2014 
caHIS1F CCT GCA GCT GAT ATC CCA GT Glory, 2014 
caHIS1R ACT GGG ATA TCA GCT GCA GG Glory, 2014 
caARGF ACT ATG GAT ATG TTG GCT ACT Glory, 2014 




Table 3: Plasmids used throughout the course of this study 
 
Plasmid Description Source 
pBS-CaURA3 pBluescript-CaURA3 A.J.P Brown 
 
pBS-CaHIS1 pBluescript-CaHIS1 C. Bachewich 
 
pFA-TAP-CaARG4 pFunctional Analysis Casette-
TAP-ARG4 
Lavoie et al., 2008 
pFA-TAP-CaHIS1 pFunctional Analysis Casette-
TAP-HIS1 
Lavoie et al., 2008 
pFA-HA-CaURA3 pFunctional Analysis Casette-
HA-URA3 
Lavoie. et al., 2008 
pMG2093 pFA6a-13myc-TRP1 ligated 
into pFA-GFP-HIS1 
Bensen, E. et al., 2005 
pFA-MET3-CaHIS1 MET3 promotor-CaHIS1 Gola, S. et al., 2003 
 
 
2.2 Medium and growth conditions  
Most strains were grown at 30C in YPD medium containing 1% yeast extract, 2% 
peptone and 2% glucose. Conditional strains were grown in synthetic complete minimal medium 
(MM) containing 0.67% of yeast nitrogen base, 2% dextrose and amino acid supplements with or 
without the addition of 2.5 mM methionine and 0.5 mM cysteine for repression and induction of 
the MET3 promoter, respectively (91). MM media was supplemented with 100 mg/L uridine, 
histidine or arginine to allow for growth of URA3+, HIS1+ or ARG4+ auxotrophs with the 
exception of selective conditions. For growth assays and collection of cells for protein extraction, 
strains were incubated overnight in medium at 30°C, diluted into fresh medium to an O.D600nm of 
0.1, and incubated until the O.D.600nm reached 0.8-1.0 or for specific time points.  
 
2.3 Strain Construction 
2.3.1 esp1::HIS1/ESP1-TAP-URA3 
In order to tag the C-terminus of ESP1 with the TAP epitope (Protein A and Calmodulin-
binding protein separated by a tobacco etch virus (TEV) protease cleavage site) (92), the 3.0 kb 
TAP-URA3 cassette was amplified from plasmid pFA-TAP-URA3 (92) with oligonucleotides 
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AG103F and AG103R, which contained 100bp of  homology to either side of the STOP codon of 
ESP1 and 20 bp homology to the plasmid. The PCR reaction mixture consisted of 0.4 mM 
d’NTPs, 100 ng of DNA template, 0.6 μM oligonucleotides, 10X Buffer and 3.75U of Expand 
Long Template Polymerase (Roche). The reaction conditions were as follows: 94°C for 4 min, 
followed by 25 cycles of 94°C for 1 min, 40°C for 1 min, 68°C for 2 min, 59 sec, 68°C followed 
by a 7 min extension, and storage at 4°C. The PCR product was cleaned (Omega PCR 
purification kit) and 8.0 μg of the product was transformed into strain BWP17, resulting in strain 
AG636.  
 Next, the second copy of ESP1 was knocked out using a two-step PCR reaction. First, a 
500 bp fragment corresponding to the 5’ flank of ESP1, located just before the START codon, 
was PCR amplified from gDNA with oligonucleotides SS1F and SS1R. The thermocycling 
conditions included: 94°C for 3 min, followed by 25 cycles of 94°C for 30 sec, 46°C for 30 sec, 
68°C for 30 sec, and a final elongation at 68°C for 7 min. The reaction mix was composed of a 
final concentration of 0.6 µM of oligonucleotides, 0.4 mM dNTPs, 100 ng of gDNA as template, 
3.75U of Expand Long Template Polymerase, and 1X Buffer 3. A 545 bp fragment 
corresponding to the 3’ flank of ESP1, starting 545 bp after the stop codon, was similarly 
amplified using oligonucleotides SS2F and SS2R and the following thermo-cycling conditions: 
94°C for 3 min, followed by 25 cycles of 94°C for 30 sec, 46°C for 30 sec, 68°C for 35 sec, and a 
final elongation at 68°C for 7 min. The reaction mix composition was similar to that used for the 
5’ flank. In order to amplify the 1348 bp HIS1 cassette fragment from plasmid pBS-CaHIS1, 
oligonucleotides SS3F and SS3R were used, which contain homology to the plasmid plus 
additional 30 bp sequences bearing homology to oligonucleotides SS1R and SS2F, respectively.  
The following thermocycling conditions were used: 94°C for 3 min, followed by 25 cycles of 
94°C for 30 sec, 40°C for 30 sec, 68°C for 1 min 25 sec, and a final elongation at 68°C for 7 min.  
The reaction mix was composed of a final concentration of 0.6 µM of oligonucleotides, 0.4 mM 
dNTPs, 100 ng of pBS-CaHIS1 as template, 3.75U of Expand Long Template Polymerase, and 
1X Buffer 3.  In order to create the final construct for transformation, oligonucleotides SS1F and 
SS2R were used at a concentration of 0.6 µM with a 1:2:1 (50ng:100ng:50ng) amount of 5’ 
fragment, marker and 3’ fragment, in a reaction including 0.4 mM of dNTPs, 3.75U of Expand 
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Long Template Polymerase, and 1X Buffer 3.  The following thermocycling conditions were 
used: 94°C for 3 min, followed by 25 cycles of 94°C for 30 sec, 50°C for 30 sec, and 68°C for 2 
min 24 sec, and a final elongation at 68°C for 7 min.  The cleaned construct was transformed into 
strain AG636 (ESP1/ESP1-TAP-URA3), resulting in strains SS1 and SS5 (esp1::HIS1/ESP1-
TAP-URA3). 
 
2.3.2 ESP1/ESP1-TAP-ARG4, cdc20::URA3/MET3::CDC20-HIS1 
In order to TAP tag ESP1 in a strain carrying a single copy of CDC20 under control of the 
MET3 promoter, strain HCCA109 (cdc20::URA3/MET3::CDC20-HIS1), the strategy described 
above was followed with the exception of using plasmid pFA-TAP-ARG4 with oligonucleotides 
AG103F and AG103R. Purified product (7.1 g) was transformed into strain HCCA109, 




In order to tag the C-terminus of ESP1 with the hemagglutinin (HA) epitope  (92), the 1.9 
kb HA-URA3 cassette was amplified from plasmid pFA-HA-URA3 (92) with oligonucleotides 
AG103F and AG103R, which contained 100 bp of  homology to either side of the STOP codon of 
ESP1 and 20 bp homology to the plasmid. The PCR reaction mixture consisted of 0.4 mM 
d’NTPs, 100 ng worth of the DNA template, 0.6 μM oligonucleotides, 10X Buffer and 3.75U of 
Expand Long Template Polymerase (Roche). The reaction conditions were as follows: 94°C for 4 
min, followed by 25 cycles of 94°C for 1 min, 40°C for 1 min, 68°C for 1 min 57 sec, 68°C 
followed by a 7 min extension, and storage at 4°C. The PCR product was cleaned and 7.1 μg was 
transformed into strain BWP17, resulting in strains SS16, SS17, SS18 and SS19 (ESP1/ESP1-
HA-URA3).  
 
2.3.4 esp1::URA3/ MET3::ESP1-HIS1 
In order to construct a strain carrying a single copy of ESP1 under control of the MET3 
promoter, one copy of ESP1 was deleted from strain BWP17 using a two-step PCR reaction as 
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described previously, with the exception of utilizing pBS-CaURA3 in place of pBsCaHIS1. In 
order to amplify the 1481 bp URA3 cassette fragment from plasmid pBS-CaURA3, 
oligonucleotides SS3F and SS3R were used, which contain homology to the plasmid plus 
additional 30 bp sequences bearing homology to oligonucleotides SS1R and SS2F, respectively.  
The following thermocycling conditions were used: 94°C for 3 min, followed by 25 cycles of 
94°C for 30 sec, 40°C for 30 sec, 68°C for 1 min 28 sec, and a final elongation at 68°C for 7 min.  
The reaction mix was composed of a final concentration of 0.6 µM of oligonucleotides, 0.4 mM 
dNTPs, 100 ng of pBS-CaHIS1 as template, 3.75U of Expand Long Template Polymerase, and 
1X Buffer 3.  In order to create the 2.5kb final construct for transformation, oligonucleotides 
SS1F and SS2R were used at a concentration of 0.6 µM with a 1:2:1 (50ng:100ng:50ng) amount 
of these three PCR fragments (5’ fragment, pBS-CaURA3, and 3’ fragment), in a reaction 
including 0.4 mM of dNTPs, 3.75U of Expand Long Template Polymerase, and 1X Buffer 3.  
The following thermocycling conditions were used: 94°C for 3 min, followed by 25 cycles of 
94°C for 30 sec, 50°C for 30 sec, and 68°C for 2 min 32 sec, and a final elongation at 68°C for 7 
min.  The cleaned construct was transformed into strain BWP17 resulting in strains SS20 and 
SS21 (esp1::URA3/ESP1). 
 Next, the remaining copy of ESP1 was placed under the control of the MET3 promotor 
using a two-step PCR reaction. First, a 522 bp fragment corresponding to the 5’ flank of ESP1, 
located just before the START codon, was PCR amplified from gDNA with oligonucleotides 
SS19F and SS19R. The thermocycling conditions included: 94°C for 3 min, followed by 25 
cycles of 94°C for 30 sec, 46°C for 30 sec, 68°C for 31 sec, and a final elongation at 68°C for 7 
min. The reaction mix was composed of a final concentration of 0.6 µM of oligonucleotides, 0.4 
mM dNTPs, 100 ng of gDNA as template, 3.75U of Expand Long Template Polymerase, and 1X 
Buffer 3. A 549 bp fragment corresponding to 549bp downstream of the START codon, was 
similarly amplified using oligonucleotides SS20F and SS20R and the following thermo-cycling 
conditions: 94°C for 3 min, followed by 25 cycles of 94°C for 30 sec, 46°C for 30 sec, 68°C for 
33 sec, and a final elongation at 68°C for 7 min. The reaction mix composition was similar to that 
used for the 5’ flank. In order to amplify the 2776 bp HIS1-MET3 cassette fragment from plasmid 
pFA-MET-CaHIS1, oligonucleotides SS21F and SS21R were used.  The following thermocycling 
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conditions were used: 94°C for 3 min, followed by 25 cycles of 94°C for 30 sec, 41°C for 30 sec, 
68°C for 2 min 47 sec, and a final elongation at 68°C for 7 min. The reaction mix was composed 
of a final concentration of 0.6 µM of oligonucleotides, 0.4 mM dNTPs, 100 ng of pFA-MET-
CaHIS1 as template, 3.75U of Expand Long Template Polymerase, and 1X Buffer 3. In order to 
create the final construct for transformation, oligonucleotides SS19F and SS20R were used at a 
concentration of 0.6 µM with a 1:2:1 (50ng:100ng:50ng) amount of these three PCR fragments as 
previously described, in a reaction including 0.4 mM of dNTPs, 3.75U of Expand Long Template 
Polymerase, and 1X Buffer 3. The following thermocycling conditions were used: 94°C for 3 
min, followed by 25 cycles of 94°C for 30 sec, 46°C for 30 sec, and 68°C for 3 min 51 sec, and a 
final elongation at 68°C for 7 min. The cleaned construct was transformed into strain SS20 
(esp1::URA3/ESP1), resulting in strains SS31 to SS35 (esp1::URA3/MET3::ESP1-HIS1). 
 
2.3.5 orf19.955::URA3/ORF19.955-MYC-HIS1 
  In order to tag the C-terminus of ORF19.955 with the MYC epitope, one copy of 
ORF19.955 was first deleted using a two-step PCR reaction. First, a 526 bp fragment 
corresponding to the 5’ flank of ORF19.955, located just before the START codon, was PCR 
amplified from gDNA with oligonucleotides SS22F and SS22R. The thermocycling conditions 
included: 94°C for 3 min, followed by 25 cycles of 94°C for 30 sec, 46°C for 30 sec, 68°C for 32 
sec, and a final elongation at 68°C for 7 min. The reaction mix was composed of a final 
concentration of 0.6 µM of oligonucleotides, 0.4 mM dNTPs, 100 ng of gDNA as template, 
3.75U of Expand Long Template Polymerase, and 1X Buffer 3. A 529 bp fragment 
corresponding to the 3’ flank of ORF19.955, starting 529 bp after the STOP codon, was similarly 
amplified using oligonucleotides SS23F and SS23R and the following thermo-cycling conditions: 
94°C for 3 min, followed by 25 cycles of 94°C for 30 sec, 45°C for 30 sec, 68°C for 35 sec, and a 
final elongation at 68°C for 7 min. The reaction mix composition was similar to that used for the 
5’ flank. In order to amplify the 1481 bp URA3 cassette fragment from plasmid pBS-CaURA3, 
oligonucleotides SS24F and SS24R were used, which contain homology to the plasmid plus 
additional 30 bp sequences bearing homology to oligonucleotides SS22F and SS23R, 
respectively. The following thermocycling conditions were used: 94°C for 3 min, followed by 25 
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cycles of 94°C for 30 sec, 40°C for 30 sec, 68°C for 1 min 28 sec, and a final elongation at 68°C 
for 7 min.  The reaction mix was composed of a final concentration of 0.6 µM of 
oligonucleotides, 0.4 mM dNTPs, 100 ng of pBS-CaURA3 as template, 3.75U of Expand Long 
Template Polymerase, and 1X Buffer 3. In order to create the 2.5kb final construct for 
transformation, oligonucleotides SS22F and SS23R were used at a concentration of 0.6 µM with 
a 1:2:1 (50ng:100ng:50ng) amount of these three PCR fragments, in a reaction including 0.4 mM 
of dNTPs, 3.75U of Expand Long Template Polymerase, and 1X Buffer 3. The following 
thermocycling conditions were used: 94°C for 3 min, followed by 25 cycles of 94°C for 30 sec, 
45°C for 30 sec, and 68°C for 2 min 32 sec, and a final elongation at 68°C for 7 min. The cleaned 
construct was transformed into strain BWP17 resulting in strains SS10 to SS15 
(orf19.955::URA3/ORF19.955). 
Next, the 3.8 kb MYC-HIS1 cassette was amplified from plasmid pMG2093 (83) with 
oligonucleotides SS18F and SS18R, which contained 100bp of  homology to either side of the 
STOP codon of ORF19.955 and 20 bp homology to the plasmid.  The PCR reaction mixture 
consisted of 0.4 mM d’NTPs, 100 ng worth of the DNA template, 0.6μM oligonucleotides, 10X 
Buffer and 3.75U of Expand Long Template Polymerase (Roche). The reaction conditions were 
as follows: 94°C for 4 min, followed by 25 cycles of 94°C for 1 min., 41°C for 1 min., 68°C for 3 
min, 50 sec, 68°C followed by a 7 min extension, and storage at 4°C. The PCR product was 
cleaned and 7.2 μg was transformed into strain SS10 (orf19.955::URA3/ORF19.955), resulting in 
strain SS22 (orf19.955::URA3/ORF19.955-MYC-HIS1).   
 
2.3.6 ORF19.955/ ORF19.955-MYC-HIS1, ESP1/ESP1-HA-URA3 
 The strain was created as described above with the exception of transforming 7.2μg 




In order to construct a strain carrying a single copy of ORF19.955 under control of the 
MET3 promoter, a two-step PCR reaction was conducted. First, a 472 bp fragment corresponding 
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to the 5’ flank of ORF19.955, located just before the START codon, was PCR amplified from 
gDNA with oligonucleotides SS27F and SS27R. The thermocycling conditions included: 94°C 
for 3 min, followed by 25 cycles of 94°C for 30 sec, 49°C for 30 sec, 68°C for 28 sec, and a final 
elongation at 68°C for 7 min. The reaction mix was composed of a final concentration of 0.6 µM 
of oligonucleotides, 0.4 mM dNTPs, 100 ng of gDNA as template, 3.75U of Expand Long 
Template Polymerase, and 1X Buffer 3. A 539 bp fragment corresponding to 539bp downstream 
of the START codon, was similarly amplified using oligonucleotides SS28F and SS28R and the 
following thermocycling conditions: 94°C for 3 min, followed by 25 cycles of 94°C for 30 sec, 
42°C for 30 sec, 68°C for 32 sec, and a final elongation at 68°C for 7 min. The reaction mix 
composition was similar to that used for the 5’ flank. In order to amplify the 2776 bp HIS1-MET3 
cassette fragment from plasmid pFA-MET3-CaHIS1, oligonucleotides SS29F and SS29R were 
used. The following thermocycling conditions were used: 94°C for 3 min, followed by 25 cycles 
of 94°C for 30 sec, 41°C for 30 sec, 68°C for 2 min 47 sec, and a final elongation at 68°C for 7 
min. The reaction mix was composed of a final concentration of 0.6 µM of oligonucleotides, 0.4 
mM dNTPs, 100 ng of pFA-MET3-CaHIS1 as template, 3.75U of Expand Long Template 
Polymerase, and 1X Buffer 3. In order to create the final construct for transformation, 
oligonucleotides SS27F and SS28R were used at a concentration of 0.6 µM with a 1:2:1 
(50ng:100ng:50ng) amount of these three PCR fragments, as previously described, in a reaction 
including 0.4 mM of dNTPs, 3.75U of Expand Long Template Polymerase, and 1X Buffer 3.  
The following thermocycling conditions were used: 94°C for 3 min, followed by 25 cycles of 
94°C for 30 sec, 46°C for 30 sec, and 68°C for 3 min 47 sec, and a final elongation at 68°C for 7 
min. The cleaned construct was transformed into strain SS14 (orf19.955::URA3/ORF19.955), 
resulting in strains SS23 to SS28 (orf19.955::URA3/MET3::ORF19.955-HIS1). 
 
2.3.8  TUB2-GFP-ARG4/TUB2, orf19.955::URA3/MET3::ORF19.955-HIS1 
In order to tag the C-terminus of TUB2 with the green fluorescent protein (GFP) epitope  
(100) a 3.2 kb GFP-ARG4 cassette was amplified from plasmid pFA-GFP-ARG4 (100) with 
oligonucleotides CB135F and CB135R, which contained 100bp homology to either side of the 
STOP codon of ORF19.955 and 20 bp homology to the plasmid. The PCR reaction mixture 
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consisted of 0.4mM dNTPs, 100ng of DNA template, 0.6μM oligonucleotides, 10X Buffer and 
3.75U of Expand Long Template Polymerase. The reaction conditions were as follows: 94°C for 
4 min, followed by 25 cycles of 94°C for 1 min, 36°C for 1 min, 68°C for 3 min 8 sec, 68°C 
followed by a 7 min extension, and storage at 4°C. The PCR product was cleaned and 7.0μg was 
transformed into strain SS25 (orf19.955::URA3/MET3::ORF19.955-HIS1), resulting in strain 
SS38 (TUB2-GFP-ARG4/TUB2, orf19.955::URA3/MET3::ORF19.955-HIS1). 
 
2.3.9 TUB2-GFP-ARG4/TUB2, esp1::URA3/MET3::ESP1-HIS1 
In order to tag the C-terminus of TUB2 with the green fluorescent protein (GFP) epitope  
(100) a 3.2 kb GFP-ARG4 cassette was amplified from plasmid pFA-GFP-ARG4 (100) with 
oligonucleotides CB135F and CB135R, which contained 100bp homology to either side of the 
STOP codon of ORF19.955 and 20 bp homology to the plasmid. The PCR reaction mixture 
consisted of 0.4mM dNTPs, 100ng of DNA template, 0.6μM oligonucleotides, 10X Buffer and 
3.75U of Expand Long Template Polymerase. The reaction conditions were as follows: 94°C for 
4 min, followed by 25 cycles of 94°C for 1 min, 36°C for 1 min, 68°C for 3 min, 08 sec, 68°C 
followed by a 7 min extension, and storage at 4°C. The PCR product was cleaned and 7.3 μg was 
transformed into strain SS35 (esp1::URA3/MET3::ESP1-HIS1), resulting in strain SS37 (TUB2-
GFP-ARG4/TUB2, esp1::URA3/MET3::ESP1-HIS1). 
 
2.4 Transformation of C. albicans  
C. albicans cells were transformed using a lithium acetate one-step transformation 
protocol (93, 94, 95). To prepare the One-Step-Buffer (OSB), 25 l of salmon sperm DNA (10 
mg/ml stock, Invitrogen) was first boiled for 10 min, cooled on ice for 5 min, then added to 200 
l of sterilized 1 M Lithium Acetate. Subsequently, 25 l of 4.0 M DTT was added, followed by 
800 l of 50% PEG 4000 (Sigma). The mixture was vortexed for 1 min, and 100 l of OSB 
solution was combined with 200-300 l of washed, stationary phase cells that had been 
centrifuged from culture. Approximately 5-7 g of transforming DNA in a maximum volume of 
10 l was added. The reaction mix was vortexed for 1 min and incubated overnight at 30ºC. The 
following day, the mixture was heat-shocked for 1 h at 43ºC and plated on selective solid 
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medium. After 2-3 days, transformants were streaked to single colony three times on fresh 
selective medium prior to screening. For increased transformation efficiency in the conditional 
strains, cells were grown overnight in minimal media (MM) lacking methionine and cysteine, and 
then transferred into rich YPD medium for 2 h prior to collection.  
 
2.5: Genomic DNA (gDNA) extraction  
In order to extract gDNA, (96) cells were inoculated in 5.0 mls of YPD medium or 
minimal media (MM) lacking methionine and cysteine, incubated at 30°C overnight and then 
centrifuged for 5 min at 3000 rpm. The supernatant was discarded and the pellet was washed 
once with 0.5 ml sterile distilled water. The pellet was then re-suspended in 1.0 ml of sorbitol 
buffer (1M sorbitol, 0.1M EDTA) mixed with 10.0 μl of lyticase (10U/μl) (Sigma) and 2.0 μl of 
4.0 M DTT. The mixture was incubated at 37°C for 1.5 h, centrifuged for 1 min at 13 500 rpm, 
and the supernatant was discarded. The pellet was re-suspended in 200 μl Tris-EDTA solution 
(50 mM Tris, 20 mM EDTA), 1% final SDS and incubated at 65°C for 30 min. After this 
incubation, 100 μl of 5.0 M potassium acetate (KAc) was added and the solution was gently 
mixed. The mixture was incubated on ice for 40 min, centrifuged for 10 min at 13 500 rpm, and 
the supernatant transferred to new Eppendorf tubes. An equal volume of 100% isopropanol was 
added to the supernatant, and after mixing for 1 min, the DNA pellet was collected by 
centrifuging at 13 500 rpm for 1 min. The DNA pellet was then washed with 70% ethanol, and 
re-suspended into 100 μl of TE buffer (1 mM EDTA, 10 mM Tris-HCl pH 8.0) with 2 μl of 
RNaseA (10 mg/ml, Molecular Bioproducts). DNA was incubated at 37°C for 30 min and stored 
at 4°C. Genomic DNA was quantified with a fluorometer (Hoefer DQ300) using Hoechst Dye 
(Invitrogen). 
 
2.6 PCR Screening 
PCR screening reaction mixes were composed of 0.6 μM of oligonucleotides, 0.4 mM of 
dNTPs, 100 ng of gDNA as template, 3 mM of MgCl2, 1X Taq Buffer with (NH4)2SO4 and 1U 
Taq DNA Polymerase (Fermentas). In order to confirm strains SS1 and SS5 (esp1::HIS1/ESP1-
TAP-URA3), oligonucleotide SS10F, which is located 593 bp upstream of the START codon of 
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ESP1 and CaHISR, which is nested in the HIS1 marker of plasmid pBS-CaHIS1, were utilized to 
amplify a 1130 bp DNA fragment. The reaction conditions were as follows: 95°C for 3min, 30 
cycles of 95°C for 30 sec, 43°C for 30 sec, 72°C for 1 min 8 sec, followed by a 7 min extension 
at 72 °C and storage at 4°C. Strains SS2, SS3 and SS4 (ESP1/ESP1-TAP-ARG4, 
cdc20::URA3/MET3::CDC20-HIS1) were confirmed using oligonucleotides AG104F, which lies 
594bp upstream of the STOP codon of ESP1, and AG3R, which is nested in the TAP sequence of 
pFA-TAP-ARG in order to amplify a fragment of 675bp. The PCR conditions were as follows: 
95°C for 3 min, 30 cycles of 95°C for 30 sec, 40°C for 30 sec, 72°C for 41 sec, followed by a 7 
min extension at 72 °C and storage at 4°C. In order to confirm strains SS16 to SS19 (ESP1-HA-
URA3/ESP1,) oligonucleotides AG104R, which lies 385bp downstream of the STOP codon of 
ESP1, and CaURA3R, which is nested in the URA3 marker of plasmid pFA-HA-URA3, were 
used.  The PCR conditions were as follows: 95°C for 3 minutes, 30 cycles of 95°C for 30 
seconds, 38°C for 30 seconds, 72°C for 1 min 2 sec, followed by a 7 min extension at 72 °C and 
storage at 4°C. In order to confirm strains SS31 to SS36 (esp1::URA3/MET3::ESP1-HIS1) 
oligonucleotides SS10F and CaURA3R amplified a 1802 bp band using the following conditions: 
95°C for 3 min, 30 cycles of 95°C for 30 sec, 36°C for 30 sec, 72°C for 1 min 48 seconds, 
followed by a 7 min extension at 72°C and storage at 4°C. Next, the MET3::ESP1 integration 
was confirmed using oligonucleotides SS26F, which lies 623 bp upstream of the ESP1 START 
codon, and CaHIS1R, were used with the following conditions: 95°C for 3 min, 30 cycles of 
95°C for 30 sec, 39°C for 30 sec, 72°C for 34 sec, followed by a 7 min extension at 72 °C and 
storage at 4°C.  
In order to confirm strains SS22 (orf19.955::URA3/orf19.955-MYC-HIS1), 
oligonucleotides SS25F, which lies 720 bp upstream of the START codon of ORF19.955, and 
CaURA3R, which is nested in the URA3 marker of plasmid pBS-CaURA3, were used to amplify 
a 1028 bp DNA fragment. The following PCR conditions were used: 95°C for 3 min, 30 cycles of 
95°C for 30 sec, 38°C for 30 sec, 72°C for 1 min 37 sec, followed by a 7 min extension at 72 °C 
and storage at 4°C. Next, the MYC-HIS1 integration was confirmed with oligonucleotides SS25R 
and CaHIS1F, which lie 672bp downstream of the STOP codon of ORF19.955, and nested in 
CaHIS1F, respectively. The oligonucleotides amplify a 1341bp DNA fragment. The following 
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PCR conditions were used: 95°C for 3 min, 30 cycles of 95°C for 30 sec, 38°C for 30 sec, 72°C 
for 1 min 20 sec, followed by a 7 min extension at 72 °C and storage at 4°C. The same oligos 
were used in part to confirm strains SS29 and SS30 (ORF19.955/orf19.955-MYC-HIS1, ESP1/ 
ESP1-HA-URA3). In order to confirm strains SS23 to SS28 (orf19.955::URA3/MET3::orf19.955-
HIS1), oligonucleotides SS25F and CaHISR were used to amplify a 1141bp DNA fragment. The 
following PCR conditions were used: 95°C for 3 min, 30 cycles of 95°C for 30 sec, 38°C for 30 
sec, 72°C for 1 min 8 seconds, followed by a 7 min extension at 72 °C and storage at 4°C. 
Oligonucleotides SS25F and CaURA3R were also used as described above to ensure the proper 
integration of orf19.955::URA3. 
2.7 Protein Extraction 
2.7.1 Bead-beating method 
In order to extract protein using the bead-beating method (83) cells were first inoculated 
in 2.0 ml of either YPD or minimal inducing medium without methionine and cysteine (-MC) and 
incubated overnight at 30°C. The culture was then diluted into 20 ml of YPD or -MC medium to 
an OD600nm of 0.1, and incubated at 30°C until the culture reached an OD600nm of 0.8-1.0. 
After centrifuging for 5 min at 3000 rpm and removing the supernatant, the pellet was placed in 
dry ice and stored at -80°C. The pellets were thawed on ice, re-suspended in 50 μl of RIPA buffer 
(10 mM sodium phosphate, 1% Triton X-100, 0.1% SDS, 10 mM EDTA, 150 mM NaCl, pH 7.0 , 
5 μg/ml Leupeptin, 5 μg/ml Aprotinin and 1mM AEBSF) and 200 μl of glass beads (Sigma, 425-
600) were added. Cells were homogenized in a bead-beater (Biospec, mini bead-beater-8) for 30 
seconds followed by 3 min incubation on ice five times. An additional 200 μl of RIPA buffer was 
added, and the extracts were centrifuged at 13 500 rpm for 10 min at 4°C. The supernatant was 
centrifuged at 13 500 rpm for 1 hour at 4°C, transferred to a new Eppendorf tube, and frozen at -
80°C.  
 
2.7.2 Lyophilization method 
Protein was alternatively extracted using lyophilization (97). Briefly, cell pellets were 
lyophilized in a freeze dryer for 24-48 hours (ThermoSavant, Modulyo D), ground to a fine 
powder using a mortar and pestle, and extracted with HK buffer (0.08g dry material per 1.0 ml of 
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HK buffer (25 mM TRIS pH7.5, 0.5% NP40, 300 mM NaCl, 5 mM EDTA pH 8.0, 15 mM 
EGTA pH8.0, 60 mM Beta Gly.PO4, 500 μM Na Vanadate, 10 mM Na Fluoride, 15 mM pNPP, 
1 μg/ml Pepsatin A, 10 μg/ml Leupeptin, 10 μg/ml Trypsin ChymoT inhibitor, 10 μg/ml 
Aprotinin, 10 μg/ml TPCK, 2 mM TAME, 5.0 mM Benzamidine, 250 μg/ml PMSF, and 1 mM 
DTT). Samples were vortexed for 10 sec, placed on ice for 3 min, a total of 5 trials. Extracts were 
then centrifuged at 13 500 rpm for 10 min at 4°C. The supernatant was centrifuged for 1 h at 13 
500 rpm at 4°C, and protein concentration was measured using the Bradford assay (Bio-Rad). 
 
2.8 Western Blotting 
  For Western blots, 30μg of protein was loaded onto 7.5 or 10% SDS-PAGE gels. Proteins 
were transferred to a polyvinyl difluoride (PVDF) membrane using 30 V overnight at 4°C. The 
membrane was dried and placed in a blocking solution consisting of Tris-buffered saline–Tween 
(TBST; 1.5M Tris , 137 mM NaCl, 0.1% Tween 20) containing 5.0 % skim milk for 90 min, 
followed by incubation in primary antibody solution consisting of either 0.4 μg/ml anti-HA 
antibody (12CA5; Roche) for 1.5 h, 0.2 μg/ml anti-TAP antibody (Thermo Scientific) for 1.5 h, 
or 1.0 μg/ml of anti-MYC(Santa Cruz) diluted in TBST supplemented with 2 % milk overnight at 
4°C. Blots were washed three times for 15 min in 1% TBST and incubated for 1 h in a 0.04 μg/ml 
of horseradish peroxidase-conjugated secondary antibody anti-mouse (KPL) or anti-rabbit (Santa 
Cruz).  After washing, blots were developed using ECL (GE Healthcare; Amersham ECL 
Western blotting analysis system). Blots were stripped and incubated with 0.2 μg/ml of anti-
PSTAIRE (Santa Cruz Biotechnology) as a loading control. Western blots were quantified using 
ImageJ as described previously (90). 
 
2.9 Co-Immunoprecipitation 
Overnight cultures were diluted into 1.0 L of YPD medium and incubated at 30°C until an 
OD600nm of 0.8-1.0. The culture was centrifuged for 5 min at 3000 rpm, and the remaining 
pellet was immersed in dry ice and stored at - 80°C. Protein was extracted using the 
lyophilization method described above. For Co-immunoprecipitation, Mono HA 11 Affinity 
beads (Covance) were used. A bead volume of 40 μl was centrifuged at 1500g for 2 min at 4°C 
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and bead buffer was removed. The beads were then washed 3 times with 500 μl of HK buffer by 
inverting 10 times to mix and further centrifuging for 2 min, 1500g at 4°C. Following the final 
wash, beads were added to protein extract containing 40 mg of protein, and samples were 
incubated overnight at 4°C with rocking. After centrifugation to pellet the beads, the supernatant 
was transferred to fresh Eppendorf tubes. Beads were washed five times with 1.0 mL of HK 
buffer, centrifuged, and resuspended in 500μl of HK buffer. The contents were transferred to 
fresh Eppendorf tubes and centrifuged to pellet the beads. The supernatant was removed and 
protein was eluted by boiling in 50 μl of 1X SDS sample buffer (50 mM Tris pH 6.8, 2% SDS, 
0.01% Bromophenol blue, 10% Glycerol, 100mM DTT) for 10 min. After centrifuging, the 
supernatant was removed and beads were boiled in 40 μl of 1X SDS sample buffer for 10 min.  
Eluted samples were loaded on 7.5 or 10% SDS PAGE gels for Western blotting. 
3.0 Affinity Purification 
Affinity purification was carried out according to Rigaut et al. 1999 and Liu et al. 2010.  
Strains BH440 (ESP1/ESP1, URA3+ HIS1+) and SS1 (esp1::HIS1/ESP1-TAP-URA3) were 
inoculated into 20 ml of YPD medium and grown overnight at 30°C. The overnight culture was 
diluted into 2 L of YPD and incubated in 30°C until the OD600nm reached 0.8-1.0. The culture 
was centrifuged for 5 min at 3000 rpm and the pellet stored at -80°C. Protein was extracted using 
the lyophilization method as described. The 2 L culture resulted in 235mg of input protein. 
Protein was pre-cleared by adding 500 μl of prewashed Sepharose 6B beads (Sigma) (1:1 slurry 
in HK buffer) 
protein extract was incubated with prewashed IgG Sepharose 6 Fast Flow (GE Healthcare) (1:1 
slurry in HK buffer; 250 μl bead volume) for 4 h or  overnight at 4°C. The extract and beads were 
poured into a Poly-Prep Chromatography Column (BIO-RAD). The eluate was discarded and 
beads were washed twice with 10 ml ice cold IPP300 buffer (25 mM Tris-HCl pH 8.0, 300 mM 
NaCl, 0.1% NP-40), twice with 10 ml IPP150 buffer (25 mM Tris-HCl pH 8.0, 150 mM NaCl, 
0.1% NP-40) and once with 10 ml TEV-CB (25 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% 
NP40, 0.5 mM EDTA and 1 mM DTT). 1 ml TEV CB buffer containing 10 U of Ac-TEV 
protease (Intrivogen) was then added, the column was rocked overnight at 4°C. The eluate was 
then collected and beads were washed with another 1.0 ml TEV CB buffer. To the final 2.0  ml 
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eluate, 3.0 ml of CBB (25 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM Mg acetate, 1 mM 
Imidazole, 2 mM CaCl2), 24.0 μl of 1.0 M CaCl2 and 300 μl of Calmodulin Sepharose 4B (GE 
Healthcare) was added. The mixture was rocked for 1 h at 4°C. After centrifugation, beads were 
washed twice with 1.0 ml CBB (0.1% NP-40), and once with 1.0 ml CBB (0.02% NP-40). 
Protein was eluted from the beads by two subsequent additions of 1.0 ml CEB (25 mM Tris-HCl 
pH 8.0, 150 mM NaCl, 0.02% NP-40, 1 mM Mg acetate, 1 mM Imidazole, 20 mM EGTA, 10 
mM β-mercaptoethanol). The elutions were combined and protein was precipitated by adding 
25% volume of 50% Trichloroacetic acid (TCA). The samples were kept on ice for 30 min, then 
centrifuged at 13 500 rpm for 10 min at 4°C. The supernatant was removed, and 1.0 ml of 80% 
acetone was added to wash the precipitate. The contents were then centrifuged at 13 500 rpm for 
10 min at 4°C to remove the acetone, the sample was dried on ice for 60 min. The pellet was re-
suspended in 30μl 1 X SDS sample buffer, and boiled for 10 min. Samples were loaded on an 
SDS-PAGE gel for staining with either Silver Stain (BioRad) or Coomassie blue (BioRad). For 
Coomassie Blue-staining, samples were run on gels until just entering the resolving gel (97). 
Stained gel pieces from tagged and untagged strains were cut and sent for processing and analysis 
via Orbitrap LC/MS (IRIC, University of Montreal).  
For affinity purification of the CDC20 conditional control strain AG153 
(cdc20::URA3/MET3::CDC20-ARG4, CLB2-HA-HIS1) and experimental strain SS3 
(ESP1/ESP1-TAP-ARG4, cdc20::URA3/MET3::CDC20-HIS1), strains were inoculated into 20 
ml of minimal inducing medium (-MC) and grown overnight at 30°C. The overnight cultures 
were centrifuged to remove media and diluted to an O.D. 600nm of 0.1 into 4 L of minimal 
repressing medium containing methionine and cysteine (+MC) and incubated at 30°C for 4 h. 
The cultures were centrifuged for 5 min at 3000 rpm, and the pellet stored at -80°C. Protein was 
extracted using the lyophlization method as described. A 4 L culture resulted in 330mg of input 
protein. The affinity purification was conducted as described above. 
4.0 Cell staining and imaging 
For Differential Interference Contrast (DIC) microscopy, cells were fixed in 70% ethanol 
for at least 1.0 h, washed twice with sterile water, and mounted on slides. To visualize nuclei, 
cells fixed in 70% ethanol were stained with 1.0 μg/ml of 4′, 6′-diamidino-2-phenylindole 
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dihydrochloride (DAPI; Sigma-Aldrich) for 20 min, and washed with sterile water (90). For 
Propidium iodide staining (88), 24h cultures were incubated in 10μg/μl propidium iodide (Sigma) 
for 5 min, rinsed in dH20, and mounted on slides. For visualization of -tubulin, live cultures 
were first centrifuged at 3000 rpm for 3 min, washed once in water and mounted on slides. Cells 
were imaged on a LeicaDM6000B microscope (Leica Microsystems Canada Inc., Richmond Hill, 
ON, Canada) equipped with a Hamamatsu-ORCA ER camera (Hamamatsu Photonics, 
Hamamatsu City, Japan) using either HCX PL APO 63x NA 1.40-0 oil or HCX PLFLUO TAR 
100x NA 1.30-0.6 oil objectives and the DAPI (460nm), FITC (500nm) or Texas Red (615nm) 

















3.1 Characterization of the C. albicans Separase homologue Esp1p 
 The regulation of the metaphase-to-anaphase transition in C. albicans is not well 
understood. We previously characterized the C. albicans APC/C cofactor Cdc20p and showed 
that it is important for this process and for mitotic exit (90). In order to determine its mechanisms 
of action, we sought Cdc20p targets by first searching the C. albicans genome for homologues of 
factors that bind Cdc20p in other systems. Through this approach, we found that C. albicans 
lacks the conserved Cdc20p target, securin. Blasting the C. albicans genome with securin 
sequences from S. cerevisiae, S. pombe, or A. nidulans, including Pds1p, Cut2p, or Bim1, 
respectively, or securin sequences from mammals, did not reveal any close homologues 
(http://www.candidagenome.org). We hypothesize that C. albicans may alternatively contain a 
functional securin homologue of divergent sequence, which may be revealed through determining 
the interacting proteins of Cdc20p. However, attempts to tag Cdc20p with a TAP tag were not 
successful. Alternatively, C. albicans contains an orthologue of a conserved securin-binding 
protein, the separase ESP1/ORF19.3356. Esp1p is 23.2% identical and 40.5% similar to Esp1p 
from S. cerevisiae (Table 4). C. albicans Esp1p has not been extensively characterized, although 
a recent large-scale screen of mutant strains suggested that it may be essential, and repression via 
the TET promoter resulted in filamentous growth (63). 
 
Table 4: Comparison of separase homologues in various organisms
1 
 
First Sequence Second Sequence % AA Alignment 
Identity  
% AA Alignment 
Similarity 
C. albicans S. cerevisiae 23.2 40.5 
C. albicans S. pombe 19.5 32.0 
C. albicans Homo sapiens 15.3 29.0 
S. cerevisiae S. pombe 22.7 35.7 
S. cerevisiae Homo sapiens 16.3 28.4 
S.pombe Homo sapiens 17.2 27.0 
1
Sequences obtained for C. albicans, Homo sapiens, S. cerevisiae, and S.pombe were obtained from 
Candida Genome Database (http://www.candidagenome.org), Uniprot Database (http://www.uniprot.org), 
Saccharomyces Genome Database (http://www.yeastgenome.org) and PomBase 
(http://www.pombase.org) respectively. Sequences were aligned using ClustalW (http://www.ebi.ac.uk) to 
obtain percent identity and similarity in amino acid sequence. 
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In order to characterize C. albicans Esp1p, one copy was deleted from strain BWP17, and 
the other was placed under control of the MET3 promoter (Figs. 5, 7), resulting in strains SS31 to 
SS36 (Fig. 8). When plated on solid inducing medium (-MC) at 30C for 48 h, colonies from 
strain SS35 (esp1::URA3/MET3::ESP1-HIS1) appeared normal compared to control strain 
BH440 (ESP1/ESP, URA3+, HIS1+) (Fig. 9A). However, on repressing medium (+MC), strains 
lacking Esp1p showed little growth (Fig. 9A). In liquid inducing medium, strain SS35 grew as 
normal yeast cells that were indistinguishable from those of control strain BH440 (Fig. 9B). 
However, by 5-8 h in repressing medium, cells of strain SS35 were predominantly large budded 
or multi-budded cells (Fig. 9B, Tables 5, 6). By 24 h, the majority of cells depleted of Esp1p 
were enlarged and filamentous (Fig. 9B). Similar results were obtained when strain 
esp1::URA3/TET::ESP1-HIS1 was incubated in doxycycline (Figs. S1, S2, Tables S1, S2).    
 In order to investigate the effects of long-term depletion on growth, strains BH440 and 
SS35 were incubated on solid inducing or repressing medium for several days. Strains HCCA118 
(cdc5::URA3/MET3::CDC5-HIS1) and SS25 (orf19.955::URA3/MET3::ORF19.955-HIS1), 
which regulates an essential or non-essential gene, respectively, were included for comparison. 
Little growth was observed in strain SS35 (Fig. 10), similar to depletion of the essential gene 
CDC5 and in contrast to strains BH440 and SS25. Thus, the data suggest that ESP1 is an essential 
gene, as previously reported for the TET-regulated strain (63), and its absence results in large-













































Fig 5: Strategy for replacing a single copy of a Gene of Interest (GOI) with a marker. 
Fragments coresponding to the 5’ flank region, 3’ flank region and a selectable marker were 
amplified from gDNA or plasmid pBS-URA3, HIS1 or ARG4 respectively using oligonucleotide 
pairs 1F/1R, 2F/2R, and 3F/3R respectively. The three products were combined with 





































Fig 6: One-step PCR strategy for tagging a gene with TAP, HA, MYC or GFP epitopes. 
Oligonucleotides 3F and 3R containing 100 bp homology to a gene of interest (GOI) and 20bp 
homology to a casette containing a tag and marker were used to amplify a construct that would 












































Fig 7: Strategy for creating a strain containing a single copy of a Gene of Interest (GOI) 
under control of the MET3 promotor. 
Fragments corresponding to 500 bp of 5’ flank region and 700 bp starting from the Start codon 
were amplified from gDNA using oligonucleotide pairs 1F/1R and 2F/2R respectively. 
Oligonucleotides 3F/3R were used to amplify a marker and MET3 promoter cassette from 
plasmid pFA-Marker-MET3 (Gola et al. 2003). The three products were combined in a fusion 






































Fig 8: Confirmation of An esp1::URA3/MET3::ESP1-HIS1 strain. 
(A)Map and DNA gel showing the PCR screening strategy to confirm correct integration of the 
URA3-containing construct.  Oligonucleotides SS10F and CaURA3R generate a 1802 bp band for 
the URA3 repacement. Positive strain SS20 and the negative control strain BWP17 are 
demonstrated.  (B) Map and DNA gel showing the PCR screening strategy to confirm correct 
integration of the MET3-containing construct.  Oligonucleotides SS26F and CaHIS1R generate a 
562 bp band for the MET3 integration. Positive strain SS35 and the negative control strain 
BWP17 are demonstrated. Vertical bars delineate the length of the transforming construct. 
























































Fig 9: Depletion of Esp1p results in poor growth and yeast cells forming large buds 
followed by filaments.  
(A) Strains BH440 (ESP1/ESP1, URA+HIS+) and SS35 (esp1::URA3/MET3::ESP1-HIS1) were 
streaked onto solid repressing (+MC) or inducing (-MC) medium and incubated at 30°C  for 24 h. 
B) Overnight cultures of strains BH440 or SS35 were diluted into liquid -MC or +MC medium 








































3.2 C. albicans Esp1p is required for separation of chromosomes 
 In S. cerevisiae, esp1 mutants arrest as large-budded cells with unsegregated chromatin, 
predominantly in the daughter cell. Spindles are either short or difficult to observe due to weak 
staining and/or microtubules being in disarray, due to a role for Esp1p in spindle stability (16, 
18). If C. albicans Esp1p functions as a separase, its absence should also result in a defect in 
chromosome separation. In order to test this, cells of strains BH440 (ESP1/ESP1, URA3+HIS1+) 
and SS35 (esp1::URA3/MET3::ESP1-HIS1) were incubated in inducing or repressing medium 
for 5 or 8 h, fixed and stained with DAPI. After 5 h in repressing medium, 18.7 % of control 
strain BH440 cells were in mitosis, where DAPI-stained chromatin was predominantly located as 
a single mass within one half of a large-budded cell, or through the bud neck and was not fully 
separated. The remainder were unbudded or small-budded (Fig. 11; Table 5). In contrast, 
approximately 43.9% of cells depleted of Esp1p were large-budded with a single mass of 
chromatin that was located in one half of the majority of cells, or at the bud neck in a smaller 
proportion of large-budded cells, consistent with a defect in metaphase (Fig. 11; Table 5). By 8 h, 
51% of cells from strain SS35 contained a single mass of unsegregated chromosomes and were 
either large-budded or multi-budded, the latter suggesting an uncoupling of nuclear division and 
budding. Only 10% of cells were capable of separating chromosomes, where every cell 
compartment of large-budded or multi-budded cells contained DAPI-stained DNA (Table 6). 
Similar results were obtained with strain esp1::URA3/TET::ESP1-HIS1 incubated in YPD 
medium containing doxycycline, with the exception that more cells were filamentous at 8 h (Fig. 
S2, Tables S1, S2).   
 In order to confirm the mitotic stage at which Esp1p may function, spindles were analyzed 
by tagging -tubulin with GFP in strain SS35, resulting in strain SS37 (Fig. 6). After incubation 
in inducing medium for 7 h, 27% (n=62) of cells contained short bar spindles characteristic of 
metaphase and early anaphase, while 14.5% contained telophase spindles (Fig. 12). In contrast, in 
repressing medium, 42.8 % (n=63) of cells contained short bar spindles, while only 4.7% 
contained a telophase spindle (Fig. 12). The remaining cells were either filamentous and 
contained extensive cytoplasmic microtubules that could interfere with visualization of spindles, 
or were in the yeast form where spindles were either not visible or appeared disorganized (Fig. 
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12). Notably, the strain showed transient filamentation when transferred to fresh medium, 
irrespective of composition. However, by 7 h, the majority of cells in inducing medium had 
recovered and were in a yeast form. Although tagging -tubulin results in a minor transient 
phenotype, precluding analysis of microtubule organization during earlier time points, a notable 
difference was observed in inducing vs repressing medium by 7 h, consistent with a role for 
Esp1p in early mitotic progression. Thus, absence of Esp1p impairs the segregation of 




































   
 
3 




















42.4 12.1 6.6 - - 25.8 10.6 - 
ESP1::URA3/ 
MET3::ESP1-HIS1    
(n=161) 




46.5 14.9 4.4 4.4 6.1 13.2 9.6 1.0 
         







44.5 26.4 3.4 - - 19.5 5.7 - 
ESP1::URA3/ 
MET3::ESP1-HIS1    
(n=120) 




72.0 10.3 3.7 - - 13.1 1.0 - 
1
Percentage of cells showing the indicated patterns. Strains BH440 (URA3+HIS1+), SS35 
(esp1::URA3/MET3::ESP1-HIS1), SS25 (orf19.955::URA3/MET3::ORF19.955-HIS1) were incubated in +MC 
or –MC medium for 5 h, fixed, and stained with DAPI.  
2
Includes unbudded and small-budded cells.  
3
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63.0 15.5 5.2 - 1.0 15.4 - - 
ESP1::URA3/ 
MET3::ESP1-HIS1    
(n=161) 




23.3 5.0 2.5 1.0 8.3 19.2 40.0 1.0 
         















78.0 9.6 1.0 - - 11.4 - - 
1
Percentage of cells showing the indicated patterns. Strains BH440 (URA3+HIS1+), SS35 
(esp1::URA3/MET3::ESP1-HIS1), SS25 (orf19.955::URA3/MET3::ORF19.955-HIS1) were incubated in +MC 
or –MC medium for 8 h, fixed, and stained with DAPI.  
2
Includes unbudded and small-budded cells.  
3




















































Fig 10: ESP1 is essential while ORF19.955 is not.  
Strains BH440 (ESP1/ESP1, URA+HIS1+), SS35 (esp1::URA3/MET3::ESP1-HIS1), HCCA108 
(cdc5::HIS1/MET3::CDC5-URA3) and SS25 (orf19.955::URA3/MET3::ORF19.955-HIS1) were 
















































Fig 11: Cells depleted of Esp1p impair chromatin separation. 
Strains BH440 (ESP1/ESP1, URA3+HIS1+) and SS35 (esp1::URA3/MET3::ESP1-HIS1) were 
incubated in inducing (-MC) or repressing (+MC) medium for 5 or 8 h, fixed and stained with 
DAPI. Bar: 10μm.  
esp1::URA3/ 
MET3::ESP1-HIS1 ESP1/ESP1 
+MC 5 h 
+MC 8 h 





Fig. 12: Cells depleted of Esp1p impair progression to telophase and microtubule 
organization in a proportion of cells. 
Strain SS35 (esp1::URA3/MET3::ESP1-HIS1) was incubated in inducing (-MC) or repressing 
(+MC) medium for 7 h, and imaged live on a LeicaDM6000B microscope. Bar: 10μm. An arrow 












3.3 Identification of Esp1p-interacting proteins reveals strong enrichment of a novel, 
previously uncharacterized protein, Orf19.955p 
 Since Esp1p of C. albicans may function as separase, we reasoned that one of its 
interacting proteins may be a functional homologue of a securin. In order to test this hypothesis, 
strains carrying a single copy of ESP1 tagged at the C-terminus with the Tandem Affinity 
Purification (TAP) tag composed of Protein A and calmodulin-binding peptide, separated by a 
tobacco etch virus (TEV) protease cleavage site, were created (Fig. 13A). Strains SS1 and SS5 
(esp1::HIS1/ESP1-TAP-URA3) grew at rates similar to control strain AG636 (ESP1/ESP1-TAP-
URA3), and expressed the protein, indicating that Esp1p-TAP was functional (Fig. 13B, C). Next, 
strains BH440 (ESP1/ESP1, URA3+HIS1+) and SS1 (esp1::HIS1/ESP1-TAP-URA3) were 
incubated in YPD medium to an O.D600nm of 0.8, collected and subjected to affinity purification. 
Since a silver-stained gel revealed a higher abundance of precipitated protein from strain SS1 vs. 
BH440 (Fig. S5), the affinity purification was repeated. Precipitated samples were run on an SDS 
PAGE gel until the sample just entered the resolving gel, and a single gel piece of compacted 
bands from each strain was sent for analysis via Orbitrap LC/MC (IRIC, University of Montreal) 
(97). The results demonstrate that few proteins co-precipitated with Esp1p, and Esp1p itself was 
not greatly enriched (Table 7). Of notable interest was the phosphatase Cdc14p, histones H2B, 
H4, and Orf19.6506p, which has a putative role in histone deacetylation. Of these factors, none 
were reported to physically interact with Esp1p in S. cerevisiae (http://www.yeastgenome.org).  
However, there may be an indirect interaction between Cdc14p and Esp1p in S. cerevisiae, 
through Cdc55p and Net1p intermediates (7).   
 In order to enhance detection of Esp1p and its interacting partners, ESP1 was next tagged 
with TAP in a CDC20 conditional strain, to allow for a synchronized block in mitosis (Fig. 14), 
resulting in strains SS2-4 (ESP1/ESP1-TAP-ARG4, MET3::CDC20-ARG4/cdc20::URA3 ). In 
order to investigate whether Esp1p expression levels were modulated under conditions of Cdc20p 
depletion, strain SS2 was incubated in inducing or repressing medium for 3 or 6 h, then processed 
for Western blotting. Since Esp1p-TAP was still expressed when Cdc20p was depleted (Fig. 15), 
we proceeded with the affinity purification and mass spectrometry analysis. Strains SS2 and 
control AG153 (MET3::CDC20-ARG4/cdc20::URA3, CLB2-HA-HIS1) were diluted into +MC 
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medium for 4 h prior to collection and processing. The results reveal significant enrichment of 
Esp1p compared to previous data obtained from exponential-phase cells (Table 8). Intriguingly, 
Cdc14p was also enriched, as well as a previously uncharacterized protein, Orf19.955p. 
Additional co-purifying peptides corresponded to proteins of varying function, including the heat 
shock protein HSP70, the filamentation regulator DEF1, as well as CTA3, which plays a role in 
endocytosis. Of these proteins, only the Cta3p, Ede1p interacts with Esp1p in S. cerevisiae 
(http://www.yeastgenome.org). Notably, homologues of other known interacting proteins of 
Esp1p in S. cerevisiae, including the protein kinase Cdc5p, the regulatory subunit of the protein 
phosphatase Cdc55p, the alpha-kleisin subunit of the cohesin complex Scc1p, kinetochore-
associated protein Slk19p and any securin, did not co-precipitate with C. albicans Esp1p. Further, 
histone-related proteins as identified under exponential growth conditions were not present.  
Thus, we identified some conserved but also novel interacting proteins of Esp1p in C. albicans, 





















Fig 13: Confirmation of strain esp1::HIS1/ESP1-TAP-URA3. 
(A) Map showing PCR screening strategy to confirm proper integration of the knockout gene 
construct. Oligonucleotides SS10F and CaHIS1R generate a 1130 bp band for the HIS1-
containing knockout construct. Positive strains SS1 and SS2, and the negative control strain 
BWP17 are demonstrated. Vertical bars delineate the length of the transforming construct. 
 (B) Western blot showing confirmation of ESP1-TAP. (C) Strains BH440 (ESP1/ESP1, 
URA3+HIS1+), AG636 (ESP1/ESP1-TAP-URA3), SS1 and SS2 (esp1::HIS1/ESP1-TAP-URA3) 








Fig 14: Confirmation of strain ESP1/ESP1-TAP-ARG4 in Cdc20p-conditional background. 
(A)Map and ethidium-bromide stained DNA gel showing PCR screening strategy to confirm 
proper integration of ESP1-TAP gene construct. Oligonucleotides AG104F and AG3R generate a 
675 bp band for the ESP1-TAP-containing construct. Positive strains SS2, SS3 and SS4 
(ESP1/ESP1-TAP-ARG4, cdc20::URA3/MET3::CDC20-HIS1) and the negative control strain 
BWP17 (ESP1/ESP1) are demonstrated. Vertical bars delineate the length of the transforming 






































Fig 15: Esp1p-TAP expression is not significantly modulated in the presence vs. absence of 
Cdc20p. 
Strains AG636 (ESP1/ESP1-TAP-URA3) and SS2 (ESP1/ESP1-TAP-ARG4, 
cdc20::URA3/MET3::CDC20-HIS1) were incubated in +MC or –MC medium for set times, 
collected and processed for Western blotting. Blots were incubated with anti-TAP antibody, 
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Protein lacking an ortholog 
in S. cerevisiae; member 
of a family encoded by 
FGR6-related genes in the 
RB2 repeat sequence; 
transposon mutation 
affects filamentous growth 
1
Approximately 235 mg protein extracts from 2 L cultures of strains SS1 (esp1::HIS1/ESP1-TAP-URA3) 
and BH440 (ESP1/ESP1)  incubated in YPD medium until reaching an O.D.600nm of 0.8 were subjected to 
tandem affinity purification (Rigaut et al. 1999 ; Liu et al. 2010). Elutions were TCA-precipitated and run 
just into the resolving portion of an SDS PAGE gel. The compressed bands were stained with Coomassie 
blue, cut from the gel, and analysed using an LTQ-OrbitrapElite with nano-ESI.  
2
Peptides less than 2 were excluded from the results.  
3
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1
Approximately 330 mg protein extracts from 4 L cultures of strains SS2 (ESP1/ESP1-TAP-ARG4, 
cdc20::URA3/MET3::CDC20-HIS1) and AG 153 (ESP1/ESP1) incubated in +MC medium for 4 h were 
subjected to tandem affinity purification (Rigaut et al. 1999 ; Liu et al. 2010). Elutions were TCA-
precipitated and run just into the resolving portion of an SDS PAGE gel. The compressed bands were 
stained with Coomassie blue, cut from the gel, and analysed using an LTQ-OrbitrapElite with nano-ESI. 
2
Peptides less than 2 were excluded from the results.  
3
























3.4 Orf19.955p is a Candida-specific protein with KEN and putative Destruction boxes 
 Since Orf19.955p was the most enriched interacting protein of Esp1p following Cdc14p, 
we focussed the remainder of our study on characterizing this factor and its function. ORF19.955 
contains a 978 bp open reading frame (ORF) encoding a potential protein of 325 amino acids and 
a predicted molecular weight of 36.4 kDa (Fig. 16). In a large-scale screen of TET-regulated 
strains, ORF19.955 was reported to be essential (63), and yeast cells depleted of the protein 
showed mild filamentous growth and were impaired in their ability to form hyphae in response to 
serum. However, the function of Orf19.955p remains elusive. In performing a BLAST of the 
sequence against all known organisms (http://blast.ncbi.nlm.nih.gov/Blast.cgi) or against fungi 
only using the BLAST tool at the SGD data base (http://www.yeastgenome.org) (Table 9), no 
close homologues were identified except for several Candida species.  
 If Orf19.955p were a functional homologue of a securin, we predict that it may contain 
Destruction and/or a KEN box to mediate Cdc20p-dependent degradation, as well as CDK 
consensus phosphorylation sites, as do other securins (9). In agreement with this, one KEN box 
and several putative Destruction boxes were located within Orf19.955p (Fig. 16). While Pds1p 
from S. cerevisiae has several CDK phosphorylation sites (102), Orf19.955p contains one 
minimal consensus site (Fig. 16). Although securin homologues are not well conserved at the 
sequence level, they are charged proteins (99). Consistent with this, Orf19.955p is acidic, with a 
predicted PI of 4.79, and a hydropathy index of -0.96 (http://www.candidagenome.org). Thus, 













1 MSSHIFKDIQ DKENELKTSG IRRKGIISNE NAGPLLSKDS NSRQVQQPQQ 
 
      51  TQQQQQQSKF TNKRIPLGGK NHNSNKLLLN RSQSSLNTKP TTQGITNVKP 
                                  
     101  PSLPKSNSSL GFSVVSDQPT EQQKQLPQPF VVHNEQVLPV KRKLLQDTKD 
                                  
     151  ELSQNSKRVK LEKKESNANT FTDSLTKPTQ NVLAHVDDLQ TTISSKTDQL 
                                  
     201  NSSNLTHNDI NRNNVDPVKR NSRLKAIDDL VESHWQDPIE TIPETVGAEN 
                                  
     251  NNGEQLEELD IKFFSTPNES FDIGDLDENH LANNEQKLSL ELDFEDESNV 
                                  
     301  GEIPIIEGID EEIGLTSDDL DNLLG            
 
Fig 16: Amino acid sequence of Orf19.955p. 
Orf19.955p sequence obtained from the Candida Genome Data base (CGD; 
http://www.candidagenome.org), encoding a 36.4 kDa protein.  Underlined are potential 
Destruction Box sequences (RXXLXXXXXX). A KEN box is highlighted in yellow.  Minimal 
























Sequences with Significant Alignment Score (bits) E Value 
ref|XP_002420343.1| 

































 The amino acid sequence of C. albicans Orf19.955p was retrieved from the Candida Genome Database 
(http://www.candidagenome.org) and a fungal protein BLAST was conducted within the Saccharomyces 










3.5 Co-immunoprecipitation confirms a physical interaction between Orf19.955p and 
Esp1p. 
 In order to confirm the interaction between Esp1p and Orf19.955p, strains SS16 
(ESP1/ESP1-HA-URA3), SS22 (ORF19.955/ORF19.955-MYC-HIS1) and SS29 and SS30 
(ORF19.955/ORF19.955-MYC-HIS1, ESP1/ESP1-HA-URA3) were created (Figs. 17, 18, and 19). 
When Esp1p-HA was pulled down with anti-HA beads, Orf19.955p-MYC co-precipitated (Fig 
20). However, Orf19.955p was not identified when control strain SS22 
(orf19.955::URA3/ORF19.955-MYC-HIS1) was incubated with anti-HA beads. Thus, Esp1p and 



















Fig 17: Confirmation of strain orf19.955::URA3/ORF19.955-MYC-HIS1. 
(A, B) Map and ethidium bromide DNA gel showing PCR screening strategy to confirm proper 
integration of ORF19.955-MYC gene construct. Non specifics are observed in the DNA gel in 
addition to the ORF19.955-MYC gene construct. Oligonucleotides SS25R and CaHIS1F generate 
a 1341 bp band for the ORF19.955-MYC-containing construct. Positive strains SS22 
(orf19.955::URA3/ORF19.955-MYC-HIS1) and the negative control strain BWP17 
ORF19.955/ORF19.955) are demonstrated. Vertical bars delineate the length of the transforming 


















Fig 18: Confirmation of strain ESP1/ESP1-HA-URA3. 
(A, B) Map and ethidium bromide DNA gel showing PCR screening strategy to confirm proper 
integration of ESP1-HA gene construct. Oligonucleotides AG104F and CaURA3R generate a 
1037 bp band for the ESP1-HA-containing construct. Positive strains SS16-19 (ESP1/ESP1-HA-
URA3) and the negative control strain BWP17 (ESP1/ESP1) are demonstrated. Vertical bars 






















Fig 19: Confirmation of strain ESP1/ESP1-HA-URA3, ORF19.955/ORF19.955-MYC-HIS1. 
(A, B)Map and ethidium bromide DNA gel showing PCR screening strategy to confirm proper 
integration of ORF19.955-MYC gene construct into strain SS16 (ESP1/ESP1-HA-URA3). 
Oligonucleotides SS25R and CaHISF generate a 1341 bp band for the ORF19.955-MYC-
containing construct. Positive strains SS29 and SS30 (ESP1/ESP1-HA-URA3, 
ORF19.955/ORF19.955-MYC-HIS1), positive control VC304 (MBP1/MBP1-MYC-HIS1), and the 
negative control strain BWP17 (ESP1/ESP1, ORF19.955/ORF19.955) are demonstrated. Vertical 


















Fig 20: Co-immunoprecipitation demonstrates an interaction between Esp1p and 
Orf19.955p. 
Western blots of whole cell extracts (WCE) and immune-precipitates of strains SS22 
(orf19.955::URA3/ORF19.955-MYC-HIS1) and SS29 (ORF19.955/ORF19.955-MYC-HIS1, 
ESP1/ESP1-HA-URA3), using IgG sepharose (IgG-IP) or anti-HA agarose (HA-IP). 20 μl of 
beads were incubated with 20 mg of protein overnight, washed, and boiled in SDS sample buffer 















3.6 Depletion of Orf19.955p results in a pleiotropic phenotype including cells that are 
enlarged, multi-budded or in chains, or pseudohyphal  
 In S.cerevisiae cells depleted of Pds1 show single body of chromatin lying within large 
budded cells. In order to address the function of Orf19.955p, we created a strain (SS25; 
orf19.955::URA3/MET3::ORF19.955-HIS1) containing a single copy of the gene under control 
of the MET3 promoter (Fig. 21). When plated on solid inducing medium (-MC) at 30C for 48 h, 
colonies grew normally and appeared similar to those of control strain BH440 
(ORF19.955/ORF19.955, URA3+, HIS1+) (Fig. 22A). However, on repressing medium (+MC), 
strain SS25 showed less growth, where colonies were small with some filamentation (Fig. 22A). 
After incubating in liquid- inducing or repressing medium for 5 h, strain SS25 resembled cells 
from control strain BH440 and were in various stages of yeast cell budding (Fig.22B, Table 5). 
However, after 8 h in repressing medium, cells of strain SS25 appeared enlarged compared to 
control cells, and showed a pleiotropic phenotype, where 40% were multi-budded, pseudohyphal 
or in the form of chains of yeast cells (Table 6, Fig 22B). These phenotypes, including cell 
enlargement, were more prevalent after 24 h of repression (Fig. 22B). Similar results were 
obtained when Orf19.955p was down-regulated with doxycycline from the TET promoter (Figs. 
S3, S4, Tables S1, S2).   
 In order to investigate the effects of long-term depletion on growth, strains BH440 and 
SS25 were incubated on solid inducing or repressing medium for several days. Strains SS35 
(esp1::URA3/MET3::ESP1-HIS1) and HCCA118 (cdc5::URA3/MET3::CDC5-HIS1) were 
included for comparison. In contrast to depletion of Cdc5p or Esp1p, which results in little to no 
growth, depletion of Orf19.955p resulted in some colony growth, although not as abundant as 
with control strain BH440 (Fig. 10). Similar results were obtained when Orf19.955p was depleted 
with doxycycline from the TET promoter (Fig. S3). In comparison, cells lacking Pds1p in S. 
cerevisiae are still viable but conditionally important for growth at elevated temperature (9, 22), 
and most mutants grown at restrictive temperature were large-budded cells with a single 
chromosomal mass of DNA, while the remaining cells were unbudded aneuploid cells (9). At 
permissive temperature, only 40% of cells could form colonies, which were often very small 
and/or heterogeneous in size (9). Thus, ORF19.955 is important for growth and proper yeast 
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morphology, but it may not be an essential gene, in contrast to that reported for the TET-regulated 
strain (63). Further, its absence does not phenocopy absence of Esp1p in C. albicans, or absence 































Fig 21: Confirmation of a MET3::ORF19.955-HIS1/orf19.955::URA3 strain. 
(A)Map and DNA gel showing the PCR screening strategy to confirm correct integration of the 
URA3-containing construct. Oligonucleotides SS25R and CaURA3F generate a 1.3 kb band for 
the URA3 repacement. Positive strain SS10 and the negative control strain BWP17 are 
demonstrated.(B) Map and DNA gel showing the PCR screening strategy to confirm correct 
integration of the MET3-containing construct. Oligonucleotides SS25F and CaHIS1R generate a 
1.1 kb band for the MET3 integration. Positive strain SS25 and the negative control strain 






















Fig 22: Yeast cells depleted of Orf19.955p demonstrate a pleiotropic phenotype including 
cell enlargement, multi-budding and pseudohyphal growth. 
(A)Strains BH440 (ORF19.955/ORF19.955, URA3+HIS1+) and SS25 
(orf19.955::URA3/MET3::ORF19.955-HIS1) were streaked onto repressing (+MC) or inducing (-
MC) solid medium and incubated at 30°C for 24 h. (B) Overnight cultures of strains BH440 and 
SS25 were incubated at 30°C, diluted into inducing (-MC) or repressing (+MC) medium and 




























3.7 Absence of Orf19.955 results in abnormalities in chromosome organization  
 In S. cerevisiae, pds1 mutants displayed precocious separation of chromosomes in the 
presence of microtubule inhibitors. In the absence of the drugs, 75% of PDS1 temperature-
sensitive mutants grown at restrictive temperature were large-budded cells with a single 
chromosomal mass of DNA, while the remaining cells were unbudded aneuploid cells (9, 18). 
Spindles could form, but were not fully elongated as most large-budded cells contained bar 
spindles characteristic of metaphase or were shorter in length, and cytokinesis was not impaired.  
If Orf19.955p functions as a securin in a similar manner as Pds1p, its absence should influence 
chromosome separation. In order to test this, cells of strains SS25 
(orf19.955::URA3/MET3::ORF19.955-HIS1) and BH440 (ORF19.955/ORF19.955, 
URA3+HIS1+) were incubated in inducing or repressing medium for 5 h or 8 h, fixed and stained 
with DAPI. After 5 h in repressing medium, strains BH440 and SS25 were similar in that 18.7 
and 23.7% of cells, respectively, were in mitosis, where DAPI-stained chromatin was 
predominantly located as a single mass within one half of a large-budded cell, or through the bud 
neck and was not fully separated (Fig. 23, Table 5). By 8 h, fewer cells appeared to be in mitosis 
in strain SS25 vs BH440 (Table 6). Rather, 40% were multi-budded or chains of yeast cells, in 
which all compartments contained a mass of chromosomal DNA (Table 6, Fig. 23), suggesting 
that chromosome separation was not impaired. However, 59% (n=114) of cells of strain SS25 
showed diffuse or fragmented DAPI staining, and some cells showed no staining at all, compared 
to 3.0% (n=100) of cells of strain BH440, suggesting abnormalities in chromosome organization 
and possibly separation. In comparison, 16.8 (n=119) or 24.5 (n=106) % of cells from strains 
SS25 and BH440, respectively, showed these defects in –MC inducing medium. Similar results 
were obtained with strain orf19.955::URA3/TET::ORF19.955-HIS1 incubated in YPD medium 
containing doxycycline (+DOX: 61.8% (n=123) vs. –DOX: 22.8% (n=127) (Fig S4).  
 In order to further determine whether absence of Orf19.955p influences a specific stage of 
mitosis, spindles were analyzed by tagging -tubulin with GFP in strain SS25, resulting in strain 
SS38 (Fig. 6). After incubation in inducing medium for 7 h, 22.7% of cells (n=110) contained 
short bar spindles characteristic of metaphase and early anaphase, while 11.8% contained 
telophase spindles (Fig. 24). Similar results were obtained in repressing medium, where 18.8% 
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(n=85) of cells contained short bar spindles, while 10.6% contained a telophase spindle (Fig. 24). 
However, many spindles and cytoplasmic microtubules appeared mispositioned, disrupted or 
disorganized. Although this remains to be quantified. Thus, although absence of Orf19.955p does 
not prevent separation of chromosomes, in contrast to presence of Pds1p, it does influence 
chromosome organization, raising the possibility that it could function as a securin in C. albicans, 
albeit with some mechanisms different from that of Pds1p.    
    
3.8 Orf19.955p levels increase in response to MMS-mediated DNA damage   
 Pds1p in S. cerevisiae is required to prevent anaphase initiation and mitotic exit in 
response to DNA damage (9). Under these conditions, it becomes phosphorylated in a Mec1p and 
Chk1p-dependent manner (35, 36). In order to determine whether Orf19.955p is functioning in a 
similar manner in C. albicans, strain SS22 (ORF19.955/ORF19.955-MYC-HIS1) was incubated 
in the presence or absence of the DNA-damage inducing drug methyl methanesulfate (MMS) for 
5 h, collected and processed for Western blotting to detect possible phosphorylation-dependent 
band shifts (Fig. 25). The mobility of Orf19.955p-MYC was similar in the presence vs. absence 
of MMS. However, the levels of the protein were higher in the presence vs. absence of the drug 
(Fig. 25). MMS treatment arrests mitosis and causes C. albicans yeast cells to switch to 
filamentous growth (103). It is thus possible that the increase in Orf19.955p levels is due to a 
higher proportion of cells being in mitosis in the presence of MMS. However, we cannot rule out 
the possibility of an induction of Pds1p levels, and thus a possible link between Orf19.955p and 










































Fig 23: Cells depleted of Orf19.955p demonstrate abnormal chromosomal segregation 
including fragmentation. 
Strains BH440 (ORF19.955/ORF19.955, URA3+HIS1+) and SS25 
(orf19.955::URA3/MET3::ORF19.955-HIS1) were incubated in inducing (-MC) or repressing 
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Fig. 24: Cells depleted of Orf19.955p demonstrate abnormalities in spindle and cytoplasmic 
microtubule organization and position in a proportion of cells. 
Strain SS25 (orf19.955::URA3/MET3::ORF19.955-HIS1) was incubated in inducing (-MC) or 
repressing (+MC) medium for 7 h, and imaged live on a LeicaDM6000B microscope. Bar: 10 









Fig. 25: Orf19.955p levels increase following treatment with methyl methanesulfate (MMS). 
Strain SS22 was incubated in the presence or absence of 0.02% MMS for 5 h, collected and 
processed for Western blotting. Treated (+) and untreated (-) samples (30, 10 or 5 μg) were 
loaded onto a 10% SDS gel.  Blots were incubated with anti-MYC antibody, stripped then 





















Elucidating the networks that govern mitosis in the fungal pathogen C. albicans will 
further our understanding of the basic biology of this organism, provide insights on the regulation 
of its cell proliferation, and identify potential new targets for anti-fungal therapies. However, we 
currently lack a comprehensive understanding of the various mechanisms that control mitosis in 
C. albicans. We previously characterized the APC/C cofactors Cdc20p and Cdh1p in C. albicans, 
and demonstrated that they were conserved in being important for the metaphase-to-anaphase 
transition and mitotic exit (90). However, the mutant cells showed some unexpected phenotypes, 
and C. albicans lacks a sequence homologue of a securin, a conserved target of Cdc20p that 
regulates the activity of separase, suggesting that Cdc20p and Cdh1p may also have novel 
functions and/or mechanism of action in C. albicans. This work focusses on the mechanisms of 
action of Cdc20p and determining how it may regulate the metaphase-to-anaphase transition.  In 
order to address this question, we hypothesized that C. albicans contains a divergent securin, 
which may be revealed through identifying the interacting factors of a conserved securin target, 
separase. C. albicans contains a separase homologue, ESP1, but it had not been functionally 
characterized. Here, we provide the first evidence that Esp1p is required for chromosome 
segregation in C. albicans. We subsequently identified its interacting factors using affinity 
purification followed by mass spectrometry, and the data revealed strong enrichment of 
Orf19.955p, a protein of unknown function with close homologues only in Candida species. 
Orf19.955p is not essential, but important for yeast cell growth, phenotype and chromosome 
organization, and it contains sequences that could potentially mediate Cdc20p-dependent 
degradation. However, its absence does not phenocopy absence of Esp1p, unlike the situation 
with cells lacking Pds1p or Esp1p in S. cerevisiae (9). If Orf19.955p represents a securin in C. 
albicans that regulates separase, we predict that the manner in which it does this is not identical 
to that of Pds1p in S. cerevisiae. If not a securin, Orf19.955p merits further study as a novel 
factor having a strong influence on growth and chromosome organization in an important fungal 





4.1 C. albicans Esp1p may be a functional separase 
 Separases are highly conserved regulators of chromosome segregation at the metaphase-
to-anaphase transition (14). They function to liberate cohesin subunit Scc1p from chromatin, 
allowing sister chromatid separation (14). C. albicans contains all the homologues of a conserved 
cohesion complex, including subunits Smc1p, Smc3p, and Scc1p. However, functional studies on 
this complex and subunits are lacking. C. albicans also contains a sequence homologue of a 
separase, ESP1. A large-scale mutant screen of C. albicans strains under control of the TET 
promoter recently demonstrated that ESP1 was essential and its repression resulted in filamentous 
growth (63). However, this report did not investigate a putative role in mitosis. Here, we provide 
the first functional data that supports a role for Esp1p in chromosome segregation at the 
metaphase-to-anaphase transition. First, cells depleted of the protein were predominantly in a 
large-budded state, similar to that reported for esp1 mutants in S. cerevisiae (16) and expected if 
cells were blocked in metaphase. Second, a majority of cells demonstrated unsegregated 
chromosomes that remained as a single mass in one half of the cell doublet, similar to esp1 
mutants in S. cerevisiae (16). Third, localization of tubulin revealed a higher proportion of cells 
with visible metaphase spindles and a lower proportion with telophase spindles in the absence vs. 
presence of Esp1p, as expected if cells were blocked in metaphase. However, many cells lacked 
visible spindles due to weak signal or the presence of extensive cytoplasmic microtubule arrays, 
and in some cases, bar spindles appeared split. Consistent with this, esp1 mutants in S. cerevisiae 
show spindle abnormalities, where some cells contained short bar metaphase spindles, and others 
contained discontinuous, faint or curvilinear microtubule arrays (16). Fourth, affinity purification 
of Esp1p revealed putative interactions with Cdc14p, a phosphatase involved in regulating 
mitotic exit in S. cerevisiae (25) and C. albicans (90). Although Esp1p does not interact with 
Cdc14p directly in S. cerevisiae, it indirectly acts on it through down-regulating the phosphatase 
PP2A
cdc55
, which in turn binds and phosphorylates the Cdc14 inhibitor Net1p to allow initial 
release of Cdc14p from the nucleolus during early anaphase (7). Thus, Esp1p from C. albicans 
functions in a manner consistent with a separase. Future experiments to confirm this role could 
involve determining whether Scc1p interacts with Esp1p and is released by it from chromatin; 
investigate the dynamic localization of Esp1p, and image live cells with tagged chromosomes in 
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order to deduce the timing and patterns of chromosome separation in the presence and absence of 
Esp1p, for example.   
 
4.2 Putative C. albicans Esp1p-interacting proteins include previously unidentified factors, 
suggesting additional functions  
 Separases have additional functions in other organisms, including duplication of 
centrosomes in humans (14) and reorganizing epithelial cells in D. melanogaster (26), for 
example. In S. cerevisiae, Esp1p also stabilizes the anaphase spindle through cleaving the 
kinesin-associated factor Slk19p (8), and regulates mitotic exit and Cdc14p release as part of the 
FEAR pathway (7). Accordingly, Esp1p in S. cerevisiae binds additional factors related to these 
functions, including the polo kinase Cdc5p, Slk19p and the phosphatase PP2A
cdc55
 (24, 25), for 
example. However, data obtained from affinity purification of Esp1p followed by mass 
spectrometry in C. albicans did not reveal such interactions, despite the fact that C. albicans has 
close sequence homologues of Slk19p, Cdc5p and PP2A. This could be due to the fact that Esp1p 
does not interact with these proteins or that there are methodological factors involving the affinity 
purification such as solutions being too stringent. Some spindles in Esp1p-depleted cells were 
abnormal, suggesting an additional role in spindle organization, but this requires further 
quantification and analysis, and Slk19p has not yet been characterized in C. albicans. 
Alternatively, the affinity purification data from exponential-growing cells revealed interactions 
with histones including H2B, H4 and a homologue of the histone deacetylase complex factor 
Rco1p, for example, raising the possibility of a novel role in regulating nucleosome organization 
and gene expression. These factors were not pulled out, however, when Esp1p was purified from 
cells blocked in mitosis via depletion of Cdc20p. We can also not rule out the possibility that the 
interaction between Esp1p and Cdc14p in C. albicans is unrelated to the functional association 
observed between these factors in S. cerevisiae, and may reflect direct Esp1p regulation of 
Cdc14p for an unknown function. Thus, Esp1p may have conserved but also novel functions in 
C. albicans, consistent with several other mitotic regulators in C. albicans, including Cdc5p (88), 
Cdc14p (73) Dbf4p (73), and Cdh1p (90). Collectively, the results further underscore differences 
in the mitotic machinery in C. albicans relative to other systems, including mammals.  
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 Another notable and distinct feature of Esp1p includes the fact that yeast lacking the 
protein initially blocked as large-budded cells that acquired more filamentous growth at much 
later time points. In contrast, repression of other essential genes required for early stages of 
mitosis in C. albicans results in yeast buds switching into highly elongated filaments at very early 
stages (73). For example, depletion of the mitotic polo-like kinase Cdc5p results in an initial 
block in metaphase, but by 4 h, elongated bud growth is evident. The cells continue to grow such 
that by 8 h, most cells are highly elongated filaments that change fate to the hyphal cell fate, 
possible due to maintenance of polarized growth and feedback on the hyphal signaling pathways 
(89). Yeast buds initially grow in a polar manner and switch to isometric growth in early mitosis, 
although the regulation of this switch in C. albicans is not known (69). The block in mitosis is 
hypothesized to prevent the switch in growth mode, resulting in elongated buds that eventually 
adapt a hyphal fate, which may provide a growth advantage for the pathogen in the different 
stressful environments of the host (72, 73, 89). The Esp1p-depleted phenotype does not agree 
with this model and suggests that other mechanisms are involved, and/or that Esp1p may 
influence aspects of the polar growth machinery itself. Overall this highlights the multiple 
strategies that C. albicans can employ to alter its phenotype and growth mode.  
 
4.3 Orf19.955p binds Esp1p and influences chromosome organization  
 Many organisms contain a securin as part of the regulatory network governing the 
metaphase-to-anaphase transition. These proteins are not well conserved at the sequence level, 
but in organisms where they have been characterized, there is sufficient homology to be 
identified with Blast searches. Since C. albicans lacked a sequence homologue of any known 
securin, we reasoned that it may contain a functional securin homologue that is novel in sequence 
and could be uncovered through purifying conserved securin interacting proteins. Since we could 
not successfully tag Cdc20p with TAP, we alternatively focused on affinity-purifying the 
separase Esp1p, and identified Orf19.955p.  Orf19.955p is a candidate securin based on many 
features. First, it was one of the most enriched peptides that co-purified with Esp1p, and was 
novel in sequence, in agreement with our model. Second, Orf19.955p contains putative 
destruction and KEN boxes, and contains a weak consensus motif for CDK phosphorylation, 
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similar to other securins that are targetted for destruction by Cdc20p/APC/C, and regulated in 
part by CDK phosphorylation (104). Third, Orf19.955p is acidic and charged, similar to others 
securins (99). Fourth, it influences growth and chromosome organization.  
 However, Orf19.955p demonstrated some features that were not expected if functioning in 
a similar manner as Pds1p in S. cerevisiae (9), including the null phenotype. In Orf19.955p-
depleted cells, chromosomes could clearly segregate, but frequently appeared diffuse, 
disorganized and at times fragmented, and some cell compartments or cells were missing 
chromosomes altogether. Thus, Orf19.955p clearly has an influence on chromosome organization 
and possibly separation, but not in a manner as demonstrated by Pds1p. In contrast, many pds1 
cells phenocopied esp1 cells in that they contained a single mass of unsegregated chromosomes. 
One may predict that if a securin is absent, precocious chromosome segregation should result 
from liberated separase. However, this does not occur in S. cerevisiae because Pds1p has both an 
inhibitory and activating influence on Esp1p (14). Thus, if Orf19.955p is a securin, it is not 
functioning in an identical manner as Pds1p in S. cerevisiae. We also cannot rule out the 
possibility that C. albicans does not have a securin, and uses alternative mechanisms to regulate 
Esp1p and chromosome separation. In this case, Orf19.955p remains attractive for further study 
as it represents a novel, fungal-specific factor that strongly affects yeast growth and chromosome 
organization, yet is not essential.   
  O’Meara et al. (2015) reported that ORF19.955 was essential, based on repression from 
the TET promoter. When we used the same dose of doxycycline for the TET-regulated strain, 
some residual albeit weak growth was detected on plates, and many cells were capable of 
chromosome segregation. We obtained similar results when using the MET3-regulated strain to 
repress ORF19.955. We suggest that Orf19.955p is important for growth but cells lacking the 
protein can be viable, depending on the organization of their chromosomes and whether they 
received the full complement. Successful construction of a deletion strain would clarify this issue, 
which is underway. It was also previously reported that depletion of Orf19.955p impaired the 
ability of yeast cells to form hyphae under hyphal-inducing conditions (63). Based on this and 
our demonstration of the cellular phenotypes of Orf19.955p depletion, we cannot rule out the 
possibility that Orf19.955p has other or additional functions, including an influence on the polar 
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growth machinery. Since the cellular phenotype was pleiotropic, it is not clear if the primary 
defect of Orf19.955p depletion was at the level of chromatin organization, which in turn 
influenced cell phenotype. Future experiments to further address the function of Orf19.955p and 
determine whether it is a securin include: 1) investigating whether ORF19.955 can complement 
the S. cerevisiae pds1 mutant; 2) determine whether Orf19.955p is a target of Cdc20p through 
conducting a Co-IP; 3) mutagenize the KEN and/or Destruction boxes and determine whether a 
non-degradable form can block cells in metaphase, similar to the situation with Pds1p in S. 
cerevisiae; 4) determine Orf19.955p levels during the course of a cell cycle to see whether it is 
cyclic and degraded in metaphase, as predicted for a securin; 5) identify interacting proteins of 
Orf19.955p using affinity purification followed by mass spectrometry; 6) localize the protein and 
determine any co-localization with Esp1p; 7) image live cells with tagged chromosomes in order 
to deduce the timing and patterns of chromosome separation in the presence and absence of 
Orf19.955p; and 8) conduct virulence assays with an orf9.955/orf19.955 null strain if the gene is 
not essential.  
 
4.5 Summary 
 Collectively our results provide new insights on factors that may be involved in regulating 
a key stage of mitosis, the metaphase-to-anaphase transition, and thus cell proliferation in C. 
albicans. Our work further underscores differences in the mitotic machinery in C. albicans 
relative to other systems, including mammals, which may be exploited for the purposes of new 
drug target discovery. In this context, Orf19.955p may represent an attractive target, due to the 
fact that it is fungal-specific, and strongly influences growth and aspects of chromosome 
organization. That it may not be essential is also an advantage, since drug resistance can develop 
from targeting genes essential for growth. Targeting two non-essential genes, which may be 
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Percentage of cells showing the indicated patterns. GRACE strain (esp1::URA3/TET::ESP1-HIS1) and 
GRACE strain (orf19.955::URA3/TET::ORF19.955-HIS1) were incubated in YPD medium with doxycycline 
(+DOX) or  YPD medium without doxycycline (-DOX) for 5 h, fixed, and stained with DAPI.  
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2
Includes unbudded and small-budded cells.  
3




















































Fig S1: Esp1p depletion shows inviability. 
GRACE strain esp1::URA3/TET::ESP1-HIS1 was plated on YPD medium with 10 μg/ml 

















Fig S2: Absence of Esp1p impairs chromatin separation. 
GRACE strain esp1::URA3/TET::ESP1-HIS1 was incubated in YPD medium with 10 μg/ml 
doxycycline (+DOX) or YPD medium without doxycycline (-DOX) at 30 degrees C for 5 h, fixed 

















































Fig S3: Depletion of Orf19.955p results in slow growing small colonies. 
GRACE strain orf19.955::URA3/TET::ORF19.955-HIS1 was plated on YPD medium with 10 
μg/ml doxycycline (+DOX) or YPD medium without doxycycline (-DOX) and incubated at 30C 

















Fig S4: Cells depleted of Orf19.955p show abnormalities in chromosome organization. 
GRACE strain orf19.955::URA3/TET::ORF19.955 was incubated in YPD medium with 10 μg/ml 
doxycycline (+DOX) or YPD medium without doxycycline (-DOX) at 30 degrees C for 5 h, fixed 



































Fig S5: Tandem affinity purification of Esp1p. 
Protein extracted from 2 L cultures of strains BH440 (ESP1/ESP1, URA3+HIS1+) or SS1 
(esp1::HIS1/ESP1-TAP-URA3) were subjected to tandem affinity purification. Elutions were 
TCA precipitated and run on an SDS-PAGE gel for silver staining. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
